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ABSTRACT
Lee, Heui Chang Ph.D., Purdue University, December 2016. Device Design Factors
for Enhancing The Functionality of Chronic Intracortical Microelectrodes. Major
Professor: Kevin J. Otto.
Intracortical microelectrodes are devices used in brain-computer interfaces (BCI)
to help regain lost motor, sensory, and cognitive functions of individuals with neu-
rological disorders. However, the long-term performance of microelectrode arrays is
hampered by a series of inflammatory tissue responses. The consequence of the in-
flammatory response is the formation of a dense astroglial sheath around the vicinity
of the electrode, impeding the electrical conduction between the electrode and neu-
rons. Furthermore, due to the cascade of neuroinflammatory events, the number of
neurons is significantly reduced near the electrode, manifested by decrease in signal-
to-noise ratio (SNR) and the yield of electrodes. Over time, these issues eventually
lead to the functional failure of the implant.
This study aims to investigate mechanical intervention strategies to mitigate the
effect of the biological response and prolong the lifetime of the implanted microelec-
trodes. First, the longitudinal recording performance of a modified site geometry was
evaluated. With planar silicon microelectrodes, sites placed on the edge outperformed
the sites placed on the center, demonstrated by increased number of detectable single
units with enhanced longevity. Second, the stress-strain induced biological response
was studied using various flexible electrodes. Flexible electrodes indeed reduced the
magnitude of the biological response than the traditional stiff silicon electrodes. Past
a certain flexibility level, however, the biological response did not reduce over less soft
electrodes, suggesting a flexibility threshold model. Finally, the biological response
of electrodes dip-coated with polyethylene glycol (PEG) was evaluated to resolve a
xiv
potential confound of PEG-coating used for inserting flexible electrodes. Results sug-
gest that dip-coating with PEG do not significantly alter the inflammatory biomarker
profiles around the device. Overall, findings from assessing the above mentioned in-
tervention strategies will help devising a complex multimodal solution for prolonging
the lifetime of neural implants.
11. INTRODUCTION
1.1 Background
Brain-computer interface (BCI) has the potential to help regain lost motor and
sensory functions of individuals with neurological disorders [1, 2]. By implanting a
man-made devices that can record from brain activities or artificially stimulate the
brain region, we can hear what the brain says or ask it to do certain tasks. In
the United States alone, the number of individuals with partial or total paralysis is
estimated to be up to 400,000, and about 11,000 new cases are added every year [3]. In
addition, about 3.3 million Americans suffer from visual impairment [4] and 750,000
are affected by profound hearing impairment [3]. As one might expect from the
numbers in the United States, neurological disorders are prevalent all over the world.
BCI leverages the fact that in most cases of neural disorders, the central nervous
system (CNS) is not damaged and can still serve its administrative functions. As
CNS is one of the critical organs in the body, interfacing with the CNS required a
delicate approach with appropriate devices.
Implantable microelectrodes are a type of device that can selectively target cer-
tain parts of the CNS and provide an interface between the brain tissue and external
equipments [1, 2]. Microelectrodes mainly serve two purposes: recording and stimu-
lation. Recording allows to gain information from neuronal action potential, graded
potential, or postsynaptic activities that are generated either spontaneously or from
the movement or sensation of the body [5, 6]. Similarly, stimulating neurons to arti-
ficially generate neuronal activity can invoke a particular movement or sensation in
the subject. The mechanism of the CNS generating such information is extremely
2sophisticated, but a number of successful studies have decoded the neural activities
to further the application of implantable microelectrodes [5–7].
One of the most successful neural prosthesis so far is the cochlear implant, a sen-
sory prosthetic device for individuals with an impaired peripheral auditory system
but intact central auditory pathways. Sounds recorded by an external microphone is
transmitted to the electrodes situated on the cochlea and are converted to electrical
stimuli using the well-defined tonotopic structure of the cochlea. Although not all
recipients were successful, the majority of recipients reported that they at least re-
gained the ability to understand speech [8]. Another successful application is deep
brain stimulation (DBS) for relieving parkinsonian motor deficits. This treatment
uses a microelectrode placed in the subthalamic nucleous (STN), globus pallidus in-
terna (GPi), or thalamus, to quench the tremor with electrical stimuli [9]. DBS has al-
ready been established as a successful clinical treatment for Parkinsons disease, and is
gradually expanding its applications to Alzheimers disease [10], obsessive-compulsive
disorder [11], dystonia [12,13], and epilepsy [12]. These clinically proven implants are
capable of maintaining their functionality for several years [14], presumably because
their target region, electrode size, stimulation parameters, or combination of these
factors make them resistant to functional degradation [15–17].
By contrast, intracortical devices, relatively tiny devices targeting superficial corti-
cal areas of the brain for delicate neural signal acquisition/stimulation, are more sus-
ceptible to functional degradation. Chronic foreign body response (FBR), which al-
most always occurs upon device implantation, is thought to drive the functional degra-
dation over time and eventually lead to electrode failure [18–20]. Non-penetrating de-
vices such as electroencephalography (EEG) electrodes or electrocorticography (ECoG)
electrodes are preferable in term of handling the FBR, however, their limitation is
resolution. The trade-off between invasiveness and resolution [21] makes the highly
invasive intracortical electrodes to possess a very high spatiotemporal resolution. In-
terfacing at the single neuron level provides a great potential for applications in
3neural prosthetics, demonstrated by successes in decoding algorithms based on single
unit isolation [1]. However, the chronic FBR must be controlled to fully utilize the
electrodes potential in the long run.
Chronic microelectrode failure can be categorized into several major factors: bio-
logical, material, and mechanical. Biological failure mode includes the acute inflam-
matory response followed by the chronic FBR that eventually leads to astrogliosis
formation and neuronal loss around the electrode [22–24]. Material failure mode
includes chemical/electrochemical damages to the electrode such as crack or delami-
nation of the insulation layer, site corrosion, and tip breakage that hinders an accurate
electrical signal conduction [25]. Mechanical failure mode includes damages to the
backbone wire or connector that is rather dependent on the external removal of the
headcap [26, 27]. While material and mechanical failure modes also account for a
large portion of chronic implant failure, not all implanted device experience the two
failure modes. Generally material failure starts to occur beyond 6-12 months [25]
and this is long after the biological failure affects the electrodes [28]. In addition,
mechanical failure is generally all or nothing, meaning that once it occurs the elec-
trode no longer functions but otherwise the electrode is intact. On the other hand,
biological failure mode occurs with every single electrodes, regardless of device size,
shape, and material [29]. The inevitable nature of biological failure mode requires a
significant attention to be paid in resolving the biological response to microelectrodes,
to lengthen the lifetime of neural implants.
1.2 Problem statement and specific aims
Maintaining the functional stability of intracortical microelectrodes over years
to decades is crucial for the BCI technology to be considered a viable treatment
option for individuals with neurological disorders. Despite the extensive amount of
research done to prolong the lifetime of chronic neural implants, no definitive solution
has been found yet. Our current knowledge on brain’s response to chronic neural
4implants suggest that the problem requires a nonlinear and multimodal solution.
Thus, combining mechanical, biochemical, and possibly other approaches to derive
an integrative solution is imperative. The first step to derive an ultimate solution will
be to identify which individual factor plays a dominant role in mediating the FBR.
In particular, mechanical properties need a significant improvement to minimize the
extent of injury both in acute and chronic terms. Then other intervention strategies
can be followed to cope with the minimized damage. In the body of work, mechanical
factors are modulated to mitigate the FBR and extend the lifetime of intracortical
microelectrodes. The remainder of this chapter characterizes the typical FBR and
functional degradation of neural implants. Then a problem statement is given with
three specific aims that focus on mitigating/avoiding the biological response to neural
implants.
Chapter 2 reviews the biological failure mode and mechanical interven-
tion strategies. This review explains the mechanism of biological failure and how
they have been characterized using histological and electrophysiological assessments.
The failure is manifested as degradation of the number of identifiable single units and
the SNR, and activated glial cells around the device with decreased neuronal density.
Then we discuss why device design factors are important and how they should be
modulated to lessen the injury in the insertion and indwelling period. Particularly,
flexible substrates and form factors are discussed in details as proposed strategies
for modulating those two factors are covered in the consecutive chapters. The re-
view bears the message that, while many hypothetical factors exist, decomposing
individual factors for independent validation is essential for deriving a multifactorial
solution.
Chapter 3 presents Specific Aim 1: modified site placement for improv-
ing the functionality of neural implants. Previous studies have shown that inter-
device factors such as size and architecture of the device heavily affect the chronic
performance. This aim focuses on the within-device factor, comparing sites on differ-
5ent locations along the shank cross-section. Traditional planar silicon microelectrodes
have recordable site only on the center of the shank. With the modified design having
sites on the center and edge, in vivo electrophysiological performance was compared
between the two over a chronic period. The key finding is that recording sites placed
on the edge last longer with higher yield than sites placed on the center, and this
effect diminishes with narrow devices.
Chapter 4 presents Specific Aim 2: mechanically adaptive neural im-
plants for mitigating the tissue response. Flexible intracortical microelectrodes
are considered to lessen the biological tissue response than stiff electrodes. However,
limited work has identified the impact of further increasing or decreasing the flexibil-
ity of microelectrodes on the tissue response. To this end, this aim investigated the
biological impact of four types of probes having different Young’s moduli. The sig-
nificance of this work is finding that the tissue response around the polyimide probes
were less severe than silicon probes, but probes softer than polyimide were similar
to polyimide probes. This finding suggest a possible flexibility threshold that the
beneficial effect of probe flexibility diminishes with increase in flexibility.
Chapter 5 presents Specific Aim 3: tissue responses to neural implants
dip-coated with polyethylene glycol (PEG). Flexible microelectrodes generally
have difficulty with penetrating the pia mater. Thus, PEG-coating has been used as
one of the simple methods for stiffening flexible devices for insertion. In Specific Aim
2, all of the probes were dip-coated with PEG and this might confound the study
as its influence to the FBR has not been verified previously. In this aim, a histolog-
ical comparison was performed to identify the difference between PEG-coated and
non-coated devices. Since CX3CR1-GFP mouse model was used in Specific Aim 2
the comparison was performed on CX3CR1-GFP mice as well. The significance of
this work is confirmation of the limited effects of dip-coating with PEG on intracor-
tical microelectrodes, despite the reported beneficial/detrimental effects from other
6applications. This finding has broad appeal to complement previous neural implant
studies as well as future studies that will use the simple dip-coating of PEG.
Chapter 6 concludes with how findings from the specific aims can con-
tribute toward identifying important mechanical aspects. These, combined
with other aspects, can be valuable assets for building an ultimate multimodal solu-
tion for lengthening the lifetime of neural implants.
72. A REVIEW OF BIOLOGICAL FAILURE MODE AND
MECHANICAL INTERVENTION STRATEGIES
2.1 Biological failure mode
2.1.1 Mechanism of biological failure
Degradation of the quality of recorded signals and the efficacy of electrical stim-
ulation has been reported by a number of studies [19, 20, 30, 31]. For recording elec-
trodes, the signal-to-noise ratio (SNR) and the number of action potentials gradually
decrease over time [19,20]. For stimulating electrodes, the required stimulation power
for activating a target brain area increases [12,15]. This functional decline is directly
related to the progress of the immune response at the electrode-tissue interface which
comprises acute mechanical trauma and chronic FBR.
When an electrode is inserted into the brain, it damages blood vessels, neurons, and
glial cells in its path. This initiates the wound-healing response in the CNS, which
involves release of erythrocytes, activated platelets, clotting factors, and inflammatory
factors from ruptured blood vessels to help rebuild the damaged tissue [30,32,33]. It
also induces morphological and metabolic changes such as intrusion of blood-borne
macrophages, release of various cytokines, and edema. The induced factors change
the gene expression at the injury site and recruits activated microglia/macrophages,
an immediate responder to brain tissue damage, and astrocytes, a late responder that
maintains the homeostasis of the brain tissue, from day one post-implantation [33,34].
This acute mechanical trauma is likely to be transitory since a stab injury without a
residing device has been reported to heal and regenerate [22,28,35].
8The acute mechanical trauma lasts for only a few weeks and by itself is not known
to be neurotoxic [36]. However, it is followed by a chronic and persistent FBR, which
adversely affects nearby neurons and the electrode-tissue medium, thereby playing a
significant role in the failure of electrodes. FBR can be characterized by activated
microglia and reactive astrocytes occupying the surface of the electrode after the
onset of the wound-healing process [33, 37]. Unless the foreign material is removed
from the insertion site, the FBR persistently aggravates the nearby tissue [33]. Ac-
tivated microglia attempt to phagocytose the electrode, which they will fail, they
encapsulate the material forming a dense astroglial sheath (i.e., an action referred to
as frustrated phagocytosis). The astroglial sheath is mainly composed of activated
microglia in the inner layer followed by reactive astrocytes in the outer layer, with
astrocytic sheath being the major component. The main role of astrogliosis is hy-
pothesized as brain tissues attempting to isolate the damaged region from healthy
tissues to maintain blood-brain barrier (BBB) integrity to prevent additional lym-
phocyte infiltration [38]. By isolating the electrode, however, it hinders the electrical
conduction between neurons and the electrode contacts. In addition, it creates a
neurodegenerative environment that causes nearby neurons to retract their processes
(i.e., dendritic degeneration), die off, or migrate away from the electrode [19, 39, 40].
An illustration depicting the initial injury and the FBR is depicted in Fig. 2.1.
The acute and chronic tissue response is not only the result of the reactive nature
of the CNS but also of material-related factors such as the toxicity of electrode deriva-
tives [32]. However, the brain tissue mostly undergoes a very similar acute and chronic
FBR regardless of the materials, size, and surgical techniques employed [29, 32]. It
is critical to characterize the degree and progression of the chronic FBR which is
thought to be the main cause of eventual electrode failure.
9Fig. 2.1. Schematic showing acute and chronic immune response at
the CNS. Acute response (A) involves vasculature damage, protein
absorption, and recruitment of activated microglia and reactive astro-
cytes, where chronic response (B) involves formation of an astroglial
sheath around the electrode and degeneration of neurons at its vicin-
ity. Adapted from [21] with permission.
2.1.2 Histological evaluation of intracortical microelectrode
Conducting immunohistology at multiple time points after implantation can help
characterize the progression of the tissue response. Typical biomarkers for the study of
FBR include: neuronal nuclei (NeuN) for neuronal cell bodies, neurofilament (NF) for
neurofilaments, receptor interacting protein (RIP) for oligodendrocytes, fluorojade-C
for degenerating neuronal cell bodies, glial fibrillary acidic protein (GFAP) for mature
astrocytes, vimentin for reactive astrocytes and fibroblasts, ionized calcium-binding
adapter molecule 1 (Iba1) for microglia/macrophages, CD68(ED1) for activated mi-
croglia/macrophages, immunoglobulin G (IgG) for blood plasma, and 4’,6-diamidino-
2-phenylindole (DAPI) or Hoechst for general cell nuclei. These biomarkers tell us
about the composition of glial cells and their activated states, as well as the neuronal
health and density.
One of the first studies to investigate the FBR to neural electrodes, Turner et
al., showed the time course of the tissue response at 2, 4, 6, and 12 weeks post-
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implantation [41]. They used a micromachined silicon electrode and explored the
astrocytic activity near the electrode. GFAP marker showed a large quantity of
astrocyte recruitment radially around the implant region as far as 500 µm at 2-4
week time points. As the post-implantation time increased to 6-12 weeks, the astro-
cytes became denser and more compact around the electrode forming an astroglial
sheath. Other groups have verified this time course with more extensive histology and
found that morphological changes were made to astrocytes turning them into reac-
tive state [18, 22, 42]. Proliferation and hypertrophy are the two main phenotypes of
reactive astrocytes and they become more prominent as astrogliosis develops. Stain-
ing for vimentin confirmed that the astroglial sheath is mostly composed of reactive
astrocytes, but not mature astrocytes, and a complete sheath was formed within 4
weeks [33]. As see in Fig. 2.2, a stratified astroglial sheath with activated microglia
in the inner layer and astrocytes in the outer layer is presented with ED1 and GFAP
staining.
Investigators have observed the formation of a neuronal kill zone as far as 200
µm from the implant as a consequence of the neuroinflammatory events [22, 43].
Fig. 2.2 demonstrates a loss of neurons in the vicinity of the electrode with NeuN
and NF staining. The exact mechanism of this neuronal loss/degeneration is not
well understood, but studies have suggested that pro-inflammatory cytokines such as
transforming growth factor- (TGF-), tumor necrosis factor alpha (TNF-), interleukin-
1 (IL-1), prostaglandin E2 (PGE2), and interferon- (INF-) secreted by activated
microglia/macrophages intoxicate neurons to turn them into a degenerative state.
Studies also point out the role of reactive astrocytes releasing neurotoxic factors as a
cascade reaction [44,45]. However, the inflammatory signaling pathways in the cortex
are not yet conclusive and further need to be verified.
Conventional histology requires explantation of implanted devices, resulting in sig-
nificant tissue loss surrounding the device. This limits the quantification of immuno-
labels and complicates the interpretation of brain tissue since the most important
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Fig. 2.2. Overlaid images of cell type specific markers around the
electrode track (orange oval drawn on the left). ED1, which stains for
activated microglia, shows the inflammatory phenotype at the closest
layer followed by a dense layer of GFAP representing astrocytic phe-
notype. Low intensity of NeuN and NF near the implant track within
2˜00 µm shows loss of neuronal cell bodies and processes. Adapted
from [22] with permission.
region of interest is in the proximity of the electrodes. Recently, device capture his-
tology (DCHist) was devised by Woolley et al. [46, 47]. DCHist leaves the device
intact in situ during the histological procedure, preserving the device-tissue interface
without any distortion. The key technique employed in DCHist requires a delicate
and precise handling of brain tissues. First, the brain tissue needs to be extracted
without pulling out the device with the acrylic headcap. Second, a relatively thick
slice (150-400 µm) is harvested using a vibratome. Although the slice is much thicker
than conventional histology slice, care must be taken to capture the device within it.
Fig. 2.3 depicts a good quality DCHist processed tissue slice presented by Woolley et
al. [47]. Here we only see microglial activity near the electrode but not a significant
neuronal loss. Neither a dense astroglial sheath nor a neuronal kill zone is observed
due to the fact that this data is from 1 week post-implantation and the tissue response
is still in the acute phase.
2.1.3 Electrophysiological evaluation of intracortical microelectrode
Electrophysiology (Ephys) recordings and impedance measurements can provide
real-time in vivo data from functioning electrodes in live animals. Specifically, Ephys
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Fig. 2.3. DCHist from 1 week post-implantation of a silicon micro-
electrode array. Each figure shows (A) microglia/macrophages, (B)
oligodendrocytes, (C) astrocytes, and (D) overlay of the three anti-
body labels. Scale bar is 200 µm. Adapted from [47] with permission.
recording allows us to measure the combinatorial effect of the electrode-tissue interface
and the healthy neuronal population around the implant. Impedance measurement
supplements the information of the electrode-tissue interface.
As a robust Ephys recording over long-term is our ultimate goal, its functional
stability can be used as a metric for determining the functionality of microelectrodes.
Recorded raw signals from penetrating electrodes contain multi-unit action potentials
from neurons, graded potentials, thermal noise, and motion artifacts. To discriminate
single-unit action potentials from other signals, a number of steps are required which
typically include band pass filtering of raw signals, spike detection, feature extraction,
and spike clustering [48]. After the clustering, each single-unit is distinguished from
the multi-unit cluster and this provides information on the number of neurons near the
electrode site, the firing rate/pattern, the amplitude of the spikes, and the background
noise level.
In contrast to the Ephys recording which passively records the neuronal activi-
ties, complex impedance spectra can be obtained by applying a sinusoidal voltage at
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predefined frequencies and measuring the current. A typically used frequency range
starts from 10-100 Hz and goes up to approximately 10 kHz, and resistive and ca-
pacitive impedance values can be obtained with respect to this range of frequency
input [31, 49]. Most importantly, 1 kHz impedance is known to be the fundamental
frequency of action potentials. Therefore, retaining at a low 1 kHz impedance implies
having a good electrode-tissue interface. However, it cannot be directly translated
into having a good recording performance as the status of neurons cannot be derived
with impedance measurements.
With the circuit model that describes the electrode-tissue interface, a rough esti-
mation of the degree of the FBR is made possible [31, 49]. This equivalent circuit
model divides the circuit into the electrode compartment and the tissue compart-
ment [31, 50, 51]. The electrode compartment is the electrode-electrolyte interface
described by a constant phase element. The tissue compartment is subdivided into
the resistive astroglial encapsulation layer and the complex cellular compartment.
The cellular compartment comprises the resistive extracellular medium connected in
parallel with the complex cellular membrane, which is often described as a RC com-
ponent. Complex impedance spectra can be analyzed with this model to look at how
individual compartments contribute to the overall impedance. Attempts have been
made to correlate the individual circuit component values with histological quan-
tification based on this model, but ended up with minimal successes [49]. Further
investigation is needed to verify the relationship between the individual circuit com-
ponents and the quantified measurements from histological markers.
Typically, chronic neural implants experience a decrease in recordable neuronal
activities and SNR over time [20, 30, 52–54], and an increase in the impedance [20,
31, 55]. Freire et al., used a tungsten microwire array and demonstrated that there
is a clear degradation of the quality of the Ephys recording, characterized by fewer
recorded spikes and reduced peak amplitudes (Fig. 2.4 (A)) [52]. Williams et al.,
also used a tungsten microwire array and showed that there is a constant increase in
14
impedance, characterized by impedance spectra moving to the upper-right direction in
the Nyquist plot (i.e., greater resistive and capacitive values) (Fig. 2.4 (B)) [31]. Fig.
2.5 (A) shows quantitative analyses indicating that a similar trend is also obtained
with silicon microelectrode arrays [20]. As the FBR occurs regardless of the type
of electrodes [29], these results support the idea that the FBR is the main cause of
electrode failure and must be suppressed to enhance electrodes functional longevity.
Fig. 2.5 (B) also demonstrates that the most dramatic change in the impedance
occurs up to four weeks post-implantation, and this coincides with previous findings
that glial encapsulation is well established by four weeks.
Fig. 2.4. Qualitative result of Ephys recordings and impedance mea-
surements with tungsten microwires. (A) Spike clustering result.
Each color except gray represents individual spiking activities of neu-
rons. Adapted from [52] with permission. (B) An impedance spectra
in nyquist plot from 0-7 days post-implantation. Adapted from [31]
with permission.
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Fig. 2.5. Quantitative result of Ephys recordings and impedance mea-
surements with silicon microelectrodes. (A) SNR (Vpp/(2*Noiserms))
and (B) Impedance at 1 kHz versus post-implantation time. Note that
the decrease in number of surviving animals especially at the end of
the study could have hampered the accuracy of statistical analysis.
Adapted from [20] with permission.
2.2 Mechanical intervention strategies for mitigating the biological re-
sponse
2.2.1 Form factors
Intuitively, electrodes with smaller cross-sectional area are likely to cause a smaller
mechanical injury. As they disrupt less amount of tissues, a smaller injury reduces
the microglia/macrophage recruitment to the electrode, which may further lessen the
inflammatory cascade that is generally progressive over time [23, 24]. Smaller size
not only reduces the acute injury but also reduces the chronic FBR which has to do
its presence in the brain. Recent research utilizing small size electrodes has verified
that smaller electrodes cause less severe astrogliosis and blood brain barrier (BBB)
instability [23, 56,57]. It can be due to that a large electrode block cellular signaling
pathways with its volume or a larger surface area promote glial cell attachment and
facilitate activation [58]. While smaller device is preferred in terms of the tissue re-
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sponse, a major disadvantage of using small site area is the compromise in sensitivity
of neural recordings or charge carrying capacity of microstimulation [59,60]. Depend-
ing on the application and the scope of use, the substrate size and site size need to
be adjusted accordingly.
In addition to size, electrode architecture is another important design factor to be
considered. Edell et al. have proposed several factors that may influence the FBR
including the tip shape [43]. As long as the tip is sharpened, however, differently
shaped tapered tips did not result in different degrees of tissue response, whether the
tip was a sword- or chisel-shaped. Bjornsson et al. later tested the tip angle of a
device which may affect the insertion injury [61]. Granted that this is as intuitive as
smaller size is favorable, sharp tips were favorable in reducing the FBR. Blunt-tipped
electrodes induced a more severe tissue response as they result in higher tissue strain
and vascular damage during device insertion. The sharpness of the tip, however, may
become less crucial as electrodes gets smaller.
Apart from modulating the body of the shank, site modulation can make the record-
able sites undergo less severe foreign body response (FBR) than the body of the shank.
Seymour et al. evaluated an electrode design that put sites on a lateral wing to sep-
arate the sites from the bulky shank [62, 63]. As the whole electrode can also be
thought as two separate electrodes, the shank part and the lateral wing part, it was
a reconfirmation of the concept that smaller electrodes induce less severe FBR. Their
work inspired that modulating the site placement can be an effective way of avoiding
the FBR.
Surface area of electrodes is a slightly different concept than the size of electrodes.
Since electrode is a three dimensional structure, a solid electrode and a perforated
electrode can have the same external dimension with a different tissue-contact area.
Seymour et al. first brought the concept of lattice (or perforated) design [62], and
this was further evaluated by Skousen et al. that the lattice design significantly
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reduced the FBR [64]. Since the lattice design exhibit a smaller cross-section than the
solid design, lattice structures are better suited for cells to re-establish their network
and promote isotropic diffusion of cell signaling molecules [64]. Similar to small
size, glial cell attachment can be reduced as well. Electrode perforation concept has
also been investigated in surface electrodes to enhance the electrode-tissue interface
integrity [65].
2.2.2 Flexibility
A significant difference in softness exists between the brain tissue and electrode
materials. Conventionally used substrate materials such as tungsten, silicon, plat-
inum, steel, and glass have a Youngs modulus (i.e., a measure of softness) of 6-7
orders of magnitude greater than that of the brain tissue [66, 67]. Due to this mis-
match, micromotion generated by respiratory and pulsatile movement can perturb the
surrounding tissue over a long period by exerting shear stress on the tissue and/or by
tearing off the tissue with sharp edges [68–70].
Stiffness of an electrodes depends on material properties and architecture [71].
Studies using finite-element modeling (FEM) evaluated the extent of shear stress
induced by planar type silicon probes [70, 72, 73]. These results suggest that the
implanted devices indeed generate strong stress-stress in the axial and later direction,
presumably causing mechanotransduction that leads to abnormal neuronal activity.
In vitro cell culture studies verified that an increased level of astrogliosis and neuronal
death may happen in excessive strain conditions [74]. It is not only the harmful effect
of strain that makes flexible electrode more favorable. Neurons were found to extend
their projections more actively to a preferred range of stiffness, mostly to materials
at low Youngs modulus, which further strengthens the idea that soft materials are
better for neural implant [75, 76]. These evidences suggest that using soft materials
is better for the health of surrounding neurons.
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Early generation electrodes specifically designed to meet the flexibility constraint
were polyimide-based microelectrodes [66,67,77,78]. The fabrication of these devices
involved metal sites sandwiched by thin films of polyimide using standard planar pho-
tolithographic techniques. Parylene-C was also considered to be a suitable flexible
material that serves the same purpose as polyimide [79–82]. Other types of materials
that are even more flexible than polyimide/parylene were also proposed such as or-
ganic nanocomposite [83–85] or SU-8 [86,87], or mixture of various materials [88–91].
These types of electrodes are effective in reducing the strain-stress between the tissue
and the device caused by micromotion.
Flexible substrates are generally better than rigid substrates in every aspects, how-
ever, the major disadvantage is their need for aid in insertion. Flexible devices tend
to buckle on the surface of the brain due to the difficulty in penetrating the fibrous
pia mater [70]. Insertion vehicle has been proposed as a means to provide tempo-
rary mechanical support for inserting the device into the brain. Coating with agents
that are rigid, biocompatible, and rapidly biodegradable while breaking down into
biocompatible metabolites, has also been considered. Coating devices with polyethy-
lene glycol (PEG), gelatin, carboxyl monolayer, or tyrosine-derived resorbing polymer
have been demonstrated to provide sufficient rigidity for insertion [92–95]. However,
side effects may exist as these carriers increase the insertion profile of the device, as
well as degraded byproducts may alter the nearby cellular environment.
2.2.3 Iatrogenic factors
The micromotion induced stress-strain is not only tied to the flexibility of the
electrode, but also tightly related to the tethering method. Functional electrodes are
normally tethered to the skull directly or via tethering cables to protect the device
from dislodging. This makes the device prone to inducing injuries during micromo-
tion, as the dislocation between the skull and the brain tissue is the main source of
strain-stress. By contrast, free-floating electrodes that are not tethered to the skull are
19
more likely to move along with the brain tissue, causing minimal strain-stress from
micromotion. Histological studies have verified that tethered devices cause signifi-
cantly greater immune response than un-tethered devices [42, 57, 96]. Nevertheless,
current technologies do not allow functionally active electrodes to be free-floating
mainly due to the wiring issues. Even putative wireless electronics will have signif-
icant momentum that will likely result in non-zero tethering forces. As strain-stress
effect comes from an interplay of electrode flexibility and tethering, the two factors
can be tuned jointly to overcome the confronted issue.
Another factor to be considered is the speed of insertion. A higher insertion speed
is favorable as it enables the devices to neatly penetrate the tissue without rupturing
the vessels or dragging the tissues [97–99]. Subbaroyan et al. have found that tissue
compression upon insertion may also rupture vessels that are relatively far away from
the implant site, which is more often observed with slower insertion [72]. The extent
of the tissue damage was more dependent on the speed of insertion rather than the
sharpness of the tip, although blunt and sharp tips both favored a faster insertion.
All in all, a number of studies have provided insights to the mechanical factors
influencing the chronic functionality of electrodes. However, some studies combined
their approach with several other paradigms such as surface coatings, suggesting that
the results may not be solely due to the mechanical factors. Mechanical factors need
to be individually validated to better understand the optimal combination of factors
requiring modulation.
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3. MODIFIED SITE PLACEMENT FOR IMPROVING
THE FUNCTIONALITY OF NEURAL IMPLANTS
3.1 Abstract
Objective: This study aims to identify the benefit of using edge sites over center
sites on a planar silicon microelectrode array. Methods: With Michigan Arrays having
sites on the center and edge, we have compared the single unit activities, signal-to-
noise amplitude ratio (SNR), noise level, impedance, and histology to identify the
difference between the two site locations. Wide and narrow devices were used to
evaluate if the difference was consistent and had a trend that meet the theoretical
expectation. Results: Edge sites recorded significantly more single units than center
sites on wide devices. Significant differences were observed with SNR during the first
week, but not afterwards. Edge sites also generally performed better than center
sites on narrow devices, but differences were smaller than wide devices. Conclusion:
Edge sites are more suitable for single unit recordings. The benefit of edge sites
decreases as the distance to center sites decreases. Significance: We showed that
a simple alteration to the site placement can greatly enhance the functionality of
silicon microelectrodes. This study promotes assessing within-device factors that can
provide an alternative pathway for lengthening the lifetime of neural implants.
3.2 Introduction
Intracortical microelectrodes generally fail to record or stimulate over a chronic
period [19, 20, 30, 52, 55, 100]. Several failure modes exist [100], among which the
biological failure has been extensively studied for decades as all devices, without
exception, eventually lose their functionality in the long-term largely due to the bi-
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ological tissue response. Over time, devices typically lose the capability to record
identifiable single units and the signal-to-noise amplitude ratio (SNR) of single units
is degraded [20, 52, 55]. Histology revealed that microglia/macrophages, astrocytes,
and infiltrated blood-derived products are activated and/or accumulated near the
device and that neurons are lost [22, 24, 28, 41, 101]. A number of mechanical factors
have been investigated to reduce this tissue response, including device size [56–58],
architecture [43, 62, 63], flexibility [70, 72, 83, 88], tethering [42, 57], and insertion
method [61, 97]. These studies provided insight to building an ideal intracortical
microelectrodes, the solution to which is complex and multifactorial [102,103].
Extensively studied device design factors have been mostly related to the substrate
of the device. Substrate is indeed a critical design parameter since it is served as a
mechanical support for the electrode sites and provides insulation to the underlying
wires. Substrate determines the extent of injury both in acute and chronic terms,
and thus comparing the biological response and/or recording functionality across
different substrates has been an area of interest [29, 58, 84, 86, 104]. However, in vivo
characteristics of factors within a device have not gained much attention. As Michigan
Arrays usually have multiple sites along the shank, depth dependent response was an
important finding that promoted researchers to control depth when conducting a
comparison study [46, 105, 106]. With traditional Michigan Arrays having sites only
on the center, however, the cross-sectional plane was difficult to study. Here, we
present a Michigan Array design having sites mainly on the center and edge of the
cross-sectional plane, to evaluate edge sites relative to the center sites.
Several studies laid the foundation of the concept of using edge sites. Seymour
et al. demonstrated that a thin lateral wing attached to the main shaft induces
significantly less severe tissue response than the main shaft [62], and also showed that
sites with more exposed sides can perform better than one-side exposed sites [63].
What is noteworthy, however, is that the lateral wing structures used in these studies
can be regarded as a separate shank, as its thickness and materials were different
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from the main shank. As a number of evidences support the idea that the smaller (or
thinner) the better [56–58], lateral wings superior performance over the main shank is
reasonable. However, edge sites placed on the same shank as center sites, presumably
going through a similar tissue response, but performing better than center sites is not
a fully convincing argument. To the authors knowledge, no study has been conducted
to evaluate the impact of edge sites on a single planar shank device.
The objective of this study is to identify the impact of site placement on the neural
recording performance. A preliminary study of center vs. edge sites with wide devices
was presented in [107], and we further extended the study by introducing narrow
devices as well as quantitatively analyzing single unit activities over the course of
8 weeks. Histology was also conducted to assess the hallmarks of biological tissue
response. Findings from this study are expected to help judging the importance of
within-device factors, which are often overlooked.
3.3 Materials and methods
3.3.1 Device configuration
Twenty four custom designed planar silicon microelectrode arrays (sixteen GP 1x16 249
(249 µm wide) and eight GP 1x16 132 (132 µm wide) - See Fig. 3.1 (A) for dimen-
sion, NeuroNexus, Ann Arbor, MI) were used in this study. Devices were 15 µm thick
and approximately 2.2 mm long. Within each 16 channel device, seven sites were on
the center, eight sites were on the edge, and one site was at the tip. The device shank
was connected to a ZIF connector via a flexible polyimide cable.
3.3.2 Surgical implantation
All surgeries and animal experimentation were performed under the guidance of
the Institutional Purdue University Animal Care and Use Committee.
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Fig. 3.1. (A) Device design layouts of wide microelectrodes
(GP 1x16 249) and narrow microelectrodes (GP 1x16 132). The
sword shaped device is connected to a flexible polyimide cable for
easier targeting of the brain region of interest. (B) An illustrative
picture showing bilateral implantation of devices into rats primary
motor cortex (M1).
Surgery and electrical measurements follow the same procedure as presented in
[107]. Twelve male Long-Evans rats (300-360g, Charles River, Chicago, IL) were
bilaterally implanted with microelectrodes, one device per hemisphere. Animals were
anesthetized with a mix of ketamine (75-95 mg/kg) and xylazine (5 mg/kg) and their
consciousness was checked with a pulse oximeter and toe pinch tests throughout the
surgery. Supplementary ketamine (20 mg/kg) was administered as needed to keep
the animals sedated. Body temperature was maintained with a heating pad (Stryker,
Kalamazoo, MI).
Animals head was shaved and fixed on a stereotactic frame. Head was wiped
with three alternating washes of betadine and 70% isopropyl alcohol. An incision
was made in the midline and periosteum was gently removed. Holes were made
using a microdrill (OmniDrill, World Precision Instruments, Sarasota, FL) and small
titanium screws (size 0-80) were placed into the holes. A 2 x 2 mm craniotomy,
centered at 2 mm anterior and lateral to the bregma (M1 region), was made on both
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hemispheres. Reference and ground wires of the device was wrapped multiple times
around a titanium screw, and the device shank was glued to the piezoelectric actuator
(Physik Instrumente, Karlsruhe, Germany) with a heated polyethylene glycol (PEG)
[108]. The device was inserted into the craniotomy 1.5-1.8 mm deep at 20 mm/s
(See Fig. 3.1 (B)) and saline was applied to release the actuator. The craniotomy
was covered with Gelfoam (Pfizer, New York, NY) and Kwik-Sil (World Precision
Instruments), followed by dental acrylic (Lang Dental, Wheeling, IL). Suture was
performed to minimize the wound exposure.
3.3.3 Electrophysiology and impedance measurements
Measurements were obtained from freely moving rats inside a faraday cage. Mea-
surements were taken daily up to one week post-implant (WPI) and three times a
week thereafter until the animal was sacrificed. Neural recordings were obtained us-
ing a RZ5 Bioamp Processor (Tucker-Davis Technology (TDT), Alachua, FL) with a
RA16PA Medusa preamplifier (TDT) sampled at 24415 kHz. Recordings were taken
for 10 minutes per session and the raw data were collected and stored using a cus-
tom written Matlab (MathWorks, Natick, MA) script. Electrochemical impedance
spectroscopy (EIS) were also performed followed by the neural recording using PG-
STAT128N Potentiostat (Metrohm Autolab, Utrecht, Netherlands). Three repeated
measurements of 10 Hz - 30 kHz frequency sweeps were averaged and interpolated to
draw the 1 kHz impedance value.
3.3.4 Post processing of neural recording data
Neural signals were band pass filtered at 300 Hz - 3 kHz. Spikes were detected with
an amplitude threshold set at 4 times the noise level σN (=median(abs(signal))/0.6745
[109]) and 1.3 ms of waveform snippets were collected. To reject artifacts appearing
as neural spikes, threshold crossing snippets were discarded if (1) the peak amplitude
was greater than 20 times σN or, (2) a peak occurred simultaneously (within 0.2
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ms) on a distant channel (greater than 150 um apart) with greater than 70% of the
peak amplitude. The reasoning behind this procedure is to mainly remove impulses of
movement artifacts that are generally correlated across the channels [110,111]. Spikes
were sorted in the 3D principal component domain with Scanning K-means clustering
method using the Offline Sorter V3 (Plexon, Dallas, TX). Sorted units with a firing
rate of greater than 0.5 Hz (i.e., >300 units in the 10 minute recording session) were
identified as recorded single units.





where µpp is the peak-to-peak amplitude of the sorted unit template. SNR was
calculated only on the channels with identified single units. Thus, average SNR
only accounts for the active channels to differentiate its interpretation from percent
activity.
3.3.5 Statistical analysis
Using Matlab, paired t-tests were run to identify the differences between site
locations (i.e., center vs edge, and lower vs upper) at a given period while blocking
inter-animal variabilities. In addition, an Analysis of Covariance (ANCOVA) was also
conducted to identify the difference over the entire 8 weeks. No significant interaction
effects were observed between any of the site locations and any times post-implant.
3.3.6 Histology
Animals were deeply anesthetized and transcardially perfused with phosphate-
buffered saline (PBS) and 4% paraformaldehyde solution (PFA). Heads were col-
lected and post fixed in PFA for 24 hours at 4 ◦C. After rinsing the heads with PBS
several times, brains were carefully extracted with either explanting the device for
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conventional histology (100 µm horizontal sections) or preserving the device in situ
for Device-Capture Histology (DCHist) (400 µm coronal section) [47]. Brains were
sectioned using a vibratome (VT1000S, Leica Microsystems, Wetzlar, Germany) and
placed in Hepes-Buffered Hanks Solution (HBHS) containing sodium azide [47] at 4
◦C until the immunostaining procedure.
Briefly, tissue slices were incubated in NaBH4 in HBHS (5 mg/ml) for 30 minutes.
Tissues were washed 3 times with HBHS for 5 minutes each and blocked in Wash
Solution (1% v/v goat serum, 0.3% v/v Triton-X in HBHS) for 2 hours. Primary
antibodies (1:400 mouse anti-NeuN (MAB377, Millipore), 1:400 chicken anti-GFAP
(AB5541, Millipore), 1:400 rabbit anti-Iba1 (019-19741, Wako Chemicals)) diluted in
Wash Solution were applied to the tissues and allowed to incubate for 48 hours at 4
◦C. Then, tissues were washed with Wash Solution 6 times for 5 minutes each followed
by 6 times for 1 hour each. Secondary antibodies (1:400 goat raised matching pairs
for primaries) diluted in Wash Solution were applied and allowed to incubate for 48
hours at 4 ◦C. After rinsing with Wash Solution 6 times for 5 minutes each and 6
times for 1 hour each, tissues were incubated in the glycerol-based U2-Scale optical
clearing solution (4 M Urea, 30% v/v Glycerol, 0.1% Triton-X) [112] for 2-3 weeks.
U2-Scale was also used as the mounting medium for fluorescent imaging.
Coverslipped tissue slices were imaged using a laser scanning confocal microscope
(LSM710, Carl Zeiss, Jena, Germany) and Zen 2010 software (Carl Zeiss). A 10X
objective was used with four laser lines to capture emitted fluorescence at different
wavelengths (488/555/633 nm for immunolabels and 405 nm for reflection of the
device). Laser power and gain were adjusted accordingly for multiple z-stacks as the
imaging plane moved along the z-axis.
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3.4 Results
Typical lifespan of animals ranged 2-6 months and they were sacrificed for end-
point histology. No mechanical failure (loss of headcap) was observed. Devices that
were broken during the surgery or did not record any identifiable neural spikes were
excluded from the study, resulting in 8 wide devices and 7 narrow devices for compar-
ison. We have statistically compared the results of neural recordings and impedance
measurements up to 8 WPI (7 WPI bin is an aggregate of 7-8 weeks) as the number of
animals and the number of identifiable single units decreased after 8 WPI making the
results difficult to interpret. Although tip sites were in the design they were excluded
from statistical analyses due to the low number of tip sites.
3.4.1 Neural recording
As previously reported by a number of literatures [20, 30, 52, 53, 55], the quality
of the neural recordings degraded over time regardless of the device width and site
location, the two main comparisons in this study (Fig. 3.2). Unit spikes are clearly
visible in the time domain at 2 DPI with higher activities on the edge sites (Channels
9-16) than the center sites (Channels 1-7). The magnified view shows synchronized
unit spike waveforms recorded across the channels adjacent to each other. Two dis-
tinct single units identified on channel 11 are presented on the right showing well
separated clusters in the PC domain. Unit spikes at 48 DPI are not as clearly visible
as 2 DPI, also seen with the decreased signal amplitude and the decreased number
of units after sorting. Recordings from this rat was one of the quality recordings in
this study, and many of the recordings failed to continue recording single units well
before 48 DPI.
Most of the sites gradually failed to record single units over time, but the lifetime of
each site varied dramatically. Fig. 3.3 depicts the fraction of active microelectrodes,
defined as the fraction of sites recorded single units in the given time interval [55], at
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Fig. 3.2. Representative neural recordings showing degradation of
signal quality over time. Recordings from Rat044 at (A) 2 DPI and
(B) 48 DPI. On the left a typical 500 ms high-pass filtered waveform is
presented with a magnified view of the 0-50 ms interval. On the right
sorted unit templates and their representation in the 3D principal
component domain are presented. Channels 1-7 are center sites, 8 is
the tip site, and 9-16 are edge sites.
each DPI and WPI. For each animal, if a site was able to record single units on any
day within the week the site was deemed active. This survival fraction provides an
overall picture of the functionality of the sites. Single unit activities were high during
the first week and then severely degraded starting from 1 WPI. However, in almost
all of the time points, edge sites had higher activity of single units than center sites.
This was particularly pronounced with the wide devices. Not all time points were
significantly different (p<0.05) with paired t-tests, but the difference over the period
of 0-6 DPI and 0-7 WPI were both significantly different (p<0.05) with ANCOVA.
Although the trend of edge sites outperforming center sites still existed with narrow
devices, fewer time points were significantly different (p<0.05) with paired t-tests,
and over the period of 0-6 DPI and 0-7 WPI were both not significantly different
(p>0.05) with ANCOVA. Also, there was no significant difference between the wide
and narrow devices (p>0.05).
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Fig. 3.3. SNR as a function of DPI (left) and WPI (right). Heatmaps
show the average SNR of each animal and line graphs show the average
across animals. (A) Wide devices (GP 1x16 249) and (B) narrow
device (GP 1x16 132). Error bars are standard error mean. Paired
t-tests were run on each DPI and WPI (significance level: * <0.1, **
<0.05). Letters in the Rat# indicate right (R) or left (L) hemisphere.
Noise levels generally increased up to 2-3 WPI and somewhat decreased in the later
time points (Fig. 3.5). For both wide and narrow devices, the day of implantation
(0 DPI) was not the day with lowest average noise level. Noise levels decreased for
the first 1-2 DPI and then started to rise. The difference between center and edge
sites were minimal and consistent over time for both wide and narrow devices. No
statistically significant differences were observed (p>0.05) with center vs. edge sites
on the wide devices at any given time points. Center vs. edge on the narrow devices
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at 1 DPI was significantly different (p<0.05), but no other significant differences were
found to support the consistency of this observation. Also, comparisons between cen-
ter and edge sites over the entire DPI or WPI were also revealed to be not statistically
significant for both devices. Interestingly, the difference in the average noise level of
narrow devices were significantly higher than wide devices (p<0.05).
Fig. 3.4. Noise level as a function of DPI (left) and WPI (right).
Heatmaps show the average noise level of each animal and line graphs
show the average across animals. (A) Wide devices (GP 1x16 249)
and (B) narrow device (GP 1x16 132). Error bars are standard error
mean. Paired t-tests were run on each DPI and WPI (significance
level: * <0.1, ** <0.05). Letters in the Rat# indicate right (R) or
left (L) hemisphere.
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As shown in the graphs, the most dramatic changes occurred during the first week.
The fraction of active electrodes, SNR, and noise level mostly underwent 0-5 days
of recovery phase, followed by degradation. The degradation occurred abruptly that
nearly 70% of the sites actively recording single units in the first week (0 WPI) failed to
record in the second week (1 WPI). At 7 WPI, almost all sites on the wide devices lost
their functionality, and only a small fraction of sites on the narrow devices remained
functional. Degradation of SNR did not look to be as dramatic as the degradation of
fraction of active electrodes, putatively due to the lower limit of SNR being bounded
by the set threshold for spike detection (SNR of 2).
3.4.2 Impedance
Impedance spectroscopy enables a rough estimation on the state of the device-
tissue interface, as cellular and non-cellular compartments can be modeled as RC
circuits with a constant phase element [31,49,51]. Especially the magnitude of 1 kHz
impedance provides a good estimate of the signal quality of single units. Impedance
generally increased during the first few WPI and then slightly decreased or plateaued
afterwards (Fig. 3.6). ANCOVA on center vs. edge sites turned out to be not signifi-
cantly different for wide devices (p>0.05), but significantly different for narrow devices
(p<0.05). When we include tip sites to the statistical test, the differences among cen-
ter, edge, and tip sites were statistically significant for wide devices (p<0.05), but not
significant for narrow devices (p>0.05). The trend of impedance very closely followed
the trend of noise level of neural recordings. The difference between wide and narrow
devices was also statistically significant (p<0.05), as is observed with the noise level.
3.4.3 Histology
Both DCHist and conventional histology were conducted with three labels staining
for microglia/macrophages (Iba1), astrocytes (GFAP), and neuronal nuclei (NeuN).
DCHist demonstrates the gross tissue response to the implanted device along the
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Fig. 3.5. Average 1 kHz impedance magnitude as a function of WPI.
(A) Wide devices (GP 1x16 249), (B) narrow device (GP 1x16 132),
and (C) a comparison of the average of wide and narrow devices.
Error bars are standard error mean. Paired t-tests were run on each
WPI, but no statistically significant differences were found.
columnar layers (Fig. 3.7). Reflectance of the device shows that the device was
situated approximately 1.5 mm down the cortical surface and the majority of sites
were located 600-1000 µm, which is mostly layer IV and V of rats primary motor
cortex. As the focal plane of this image is on the tapered shank, and microglial and
astrocytic activities are shown to be most intense around that area. The population
of neuronal nuclei looked to be less dense around the tapered area, but an accurate
interpretation was difficult due to the angle of the device overshadowing the tissues
beneath it. Due to the limited depth of antibody penetration, GFAP and NeuN
were no longer visible after 70-100 µm into the section, whereas Iba1 maintained its
intensity up to 200-250 µm (data not shown), as previous reported [47].
Conventional histology is limited to a single depth, but provides a good represen-
tation of the cross-sectional view around the device (Fig. 3.8). A horizontal slice
image of Rat038 implanted with a wide device shows that after 6 months a compact
astroglial sheath was formed around the device. However, glial cells nearby the as-
troglial sheath were not much activated and shows a stabilized response. There was
a neuronal void sized 30-40 µm from the sheath. By contrast, images from Rat049
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Fig. 3.6. DCHist images of thick coronal sections from Rat039L im-
planted with a wide device (GP 1x16 249) for 6 months. Images are
from approximately 50 µm into the z-axis of the coronal slice. Re-
flectance of the device shows its location and angle. Orthogonal views
are presented next to the reflectance image. Scale bar is 100 µm.
implanted with a narrow device shows that after 2 months there was still an ongoing
glial cell activation around the device, without much neuronal loss near the astroglial
sheath. The size of the wide device indicate that the hole of Rat038 was stretched to
the sides while the device was residing in the brain, but shrunk upon extraction. The
narrow device of Rat049 did not look to cause serious deformation upon extraction.
3.5 Discussion
As reported by a number of studies, device-tissue interfaces established with cur-
rent technology are highly variable in nature [20, 25, 31, 52, 55]. Often it is hard to
find a meaningful conclusion as the inter-animal variability can overshadow the effect
of treatments. In this study, center vs. edge sites were compared within the same
device, successfully blocking the inter-animal variability. This significantly increased
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Fig. 3.7. Histology images of horizontal sections from rats implanted
with (A) a wide device (GP 1x16 249) for 6 months, and (B) a nar-
row device (GP 1x16 132) for 2 months. Sections were taken from
approximately 1100 µm deep from the cortical surface. Scale bars
are 100 µm. Orange rectangles shown above the Iba1 images depict
size of the respective devices. (C) A finite element modeling (FEM)
image from [113] showing relative concentration of MCP-1 and TNF-
surrounding an implanted device. Rectangles depict center and edge
sites surrounded by different concentrations of pro-inflammatory cy-
tokines. Adapted from [113] with permission.
the statistical power, shown in the results that edge sites were almost always better
than center sites at any given time point.
Single unit activities of edge sites were significantly greater than center sites on
wide devices over the course of 8 weeks. The SNR was also significantly greater in
the 0-6 DPI, but not in the 0-7 WPI, presumably because the number of single units
decreased and the average SNR lost its statistical power. Interestingly, the difference
in the SNR was not manifested in the noise level. These differences in center vs. edge
sites were also observed from narrow devices, but with a smaller difference, which
is intuitive. Keep decreasing the shank width would result in center and edge sites
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overlapping with each other, rendering no difference between the two. Center vs.
edge sites on the narrow devices did not show any statistically significant differences
in the fraction of active electrodes, SNR, and noise level. As it is seen in Fig. 3.3
(B), however, the trend of edge sites outperforming center sites seen from the wide
devices still existed.
The noise level and impedance were tightly correlated to each other. The differ-
ence of center vs. edge sites seen in Fig. 3.5 was also observed in Fig. 3.6. Unlike
single unit-related measures, these measurements did not fluctuate much as they do
not depend on the status of neurons. Although noise levels increased and single
unit activities decreased over time, it was difficult to conclude if noise level was the
dominant cause of signal loss. Sites with single unit activities in the chronic phase
(4-7 WPI) had similar noise levels compared to sites with no single unit activities.
To tease apart, it is likely that loss of identifiable single units is dictated by nearby
neuronal activity (i.e., signal source) rather than the glial encapsulation itself (i.e.,
electrical conduction), putting aside the neuroinflammation cascade initiated by acti-
vated glial cells. We observed that narrow devices had significantly higher noise level
and impedance than wide devices, which was not expected, but these did not make
a large impact on the recorded single unit activities as wide and narrow devices were
not significantly different in the fraction of active electrodes and the SNR.
Histology images provided a reasonable explanation on the difference between the
center and edge sites. Glial cells were more likely to adhere to the surface of the pla-
nar shank rather than the blades (see Fig. 3.8 (B) and [113,114]). This phenomenon
is not observed unless the device track in the tissue is well maintained until imag-
ing. As more activated glial cells are accumulated near the center of the shank, the
concentration of released pro-inflammatory cytokines may form an elliptical shape,
as modeled by Skousen et al (Fig. 3.8 (C) [113]). This explains the difference in the
neural recordings of center vs. edge sites observed in this study. It is likely that edge
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sites were more accessible to the action potentials generated from healthy neurons
near the sides of the shank.
Despite the fact that edge sites turned out to be superior to center sites, they all
went into the failure mode. Fig. 3.8 (A) shows that after 6 months the tissue response
was uniform and a significant area was absent with neurons around the device track.
Edge sites may have better neuronal contact than center sites, but it does not prevent
them from losing the functionality. As the solution to maintaining the functionality of
neural implants for a lifetime is likely to be multifactorial [103], however, the findings
from this study can contribute toward building a complex multimodal solution.
3.6 Conclusion
We have compared the chronic recording functionality of sites located on the
center and edge of planar silicon microelectrodes. Wide and narrow devices with
modified site placement were used to identify the impact of separation distance on
the electrophysiological performance. Edge sites on the wide devices significantly
outperformed center sites in terms of single unit recording capability. Edge sites on
the narrow devices generally outperformed center sites but the difference was not
statistically significant. Histology images in this study and previous studies infer
that these results are attributed to edge sites superior accessibility to nearby healthy
neurons. Our findings suggest that site geometry within a device is an important
factor and must not be overlooked when designing novel microelectrodes.
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4. MECHANICALLY ADAPTIVE NEURAL IMPLANTS
FOR MITIGATING THE TISSUE RESPONSE
4.1 Abstract
One major impediment towards advancing brain-computer interface (BCI) tech-
nology is resolving the brains biological response to neural implants. Flexible neural
probes are hypothesized to reduce the chronic foreign body response (FBR) mainly
by reducing the strain-stress caused by an interplay between the tethered probe and
the brains micromotion. However, a large discrepancy of Youngs modulus still exists
(3-6 orders of magnitude) between flexible probes and the brain tissue. This raises the
question of whether we need to bridge this gap; would increasing the probe flexibil-
ity proportionally reduce the FBR? Using novel Off-Stoichiometry Thiol-Enes-Epoxy
(OSTE+) polymer probes developed in our previous work, we quantitatively eval-
uated the FBR to four types of probes with different softness: silicon (˜150 GPa),
polyimide (1.5 GPa), OSTE+Hard (300 MPa), and OSTE+Soft (6 MPa). We ob-
served a significant reduction in the fluorescence intensity of biomarkers for activated
microglia/macrophages and blood-brain barrier (BBB) leakiness around the three
soft polymer probes compared to the silicon probe, both at 4 weeks and 8 weeks
post-implantation. However, we did not observe any consistent differences in the
biomarkers among the polymer probes. This suggests that the mechanical compli-
ance of neural probes can mediate the degree of FBR, but its impact diminishes after
a hypothetical threshold level.
38
4.2 Introduction
One primary objective of the neuroprosthetic field has been in engineering de-
vices that are capable of interfacing with the tissue for dozens of years in order for
neural implants to be considered a viable treatment option for individuals with neu-
rological disorders [21,102]. The functionality of implanted microelectrodes typically
degrades over time and is reported to be associated with a severe foreign body re-
sponse (FBR) that persists as the implant stays in the brain [22, 23]. A number
of strategies have been proposed to improve the brains FBR to neural implants via
modulating mechanical and/or biochemical aspects of the device-tissue interface [102].
In order to integrate multiple approaches to devise a complex, multimodal solution,
identifying individual factors that critically impact the FBR has been of particular
importance [103].
The development of micro-fabricated neural probes as an intracortical interface
has come a long way from Wises approach in the 1970s [115]. While the flat sword
shape design remains unchanged, the development of new materials has opened up
possibilities for improved functionality. Within the device design approach [43], the
mechanical mismatch of the soft brain tissue and the rigid neural implant has been
thought to be one of the key components that needs mediation [70, 72, 77]. Silicon
(130-180 GPa [116]), the most commonly used material for penetrating intracortical
microelectrodes has a mismatch in Youngs modulus 7-8 orders of magnitude greater
than the brain tissue (1 kPa [117]). It has been postulated that the strain-stress
caused by the rigid backbone of neural implants and brains micromotion may per-
sistently exacerbate the FBR, leading to electrode failure [68]. Both Subbaroyan et
al. and Lee et al. utilized finite element modeling (FEM) to identify that the strain
stress induced by rigid silicon probes was significantly greater than hypothetical soft
probes [70,72]. The key finding was that flexible probes decrease both tangential and
radial strains at any given degree of device tetheredness or device-tissue integration,
which was further evaluated in vivo by Sridharan et al. [118]. In vitro cell viability
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studies pertaining to mechanotransduction also suggested that excessive strain con-
ditions decrease neuronal viability [74], whereas soft substrates allow for preferential
attachment and growth of neurons over glial cells [75]. Based on these initial findings,
many groups shifted gears toward developing probes made of softer materials than
silicon, including polyimide [77, 78], parylene [81, 119], SU-8 [86, 87], nanocompos-
ites [83–85,118], and other materials [88,90,91,120,121].
Although flexible probes were found to induce significantly less strain-stress, the
impact of reduced strain-stress to both the in vivo FBR and the device performance
needed to be verified. Quantitative histological studies by the Capadona group and
the Tyler group demonstrated that nanocomposite probes, which becomes extremely
flexible (i.e., 12 MPa) when hydrated, induce significantly less neuroinflammatory
response than standard silicon probes and polyvinyl acetate (PVAc)-coated silicon
probes [84, 85]. In addition, several other studies showcased enhanced long-term
electrophysiological characteristics in the central nervous system (CNS) with flexible
surficial [122] or penetrating devices [87,104]. It was becoming more evident that flex-
ible materials are a favorable choice for neural implant substrates. However, questions
remained regarding whether the increase in flexibility reduces the FBR proportion-
ally, or only up to a certain level. Analogous to the critical surface area hypothesis
by Seymour et al. [62], there may be a critical flexibility level, beyond which the
performance benefit would plateau.
In order to evaluate probes that are softer than polyimide we used probes made
of Off-Stoichiometry Thiol-Enes-Epoxy (OSTE+) polymers, which is synthesized by
a radical-mediated thiol-ene click reaction. OSTE+ polymer was initially developed
for microfluidic devices [123] and advanced to neural implant application [120]. The
strength of the OSTE+ is its patternable nature (due to the use of UV-lithography)
and tunable Youngs modulus (by simply changing the ratio of constituents). With
this feature we created two types of OSTE+ probes made of the same materials
that are moderately soft (OSTE+Hard) and very soft (OSTE+Soft), to solely evaluate
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the effect of flexibility. Our previous in vitro study suggested that the unbound
constituents of OSTE+ were effectively removed by incubating the probe in water for
seven days [89]. The results of this study suggest that comparing conventional probes
with OSTE+ probes would reveal the consequence of flexibility on the severity of the
tissue response.
We evaluated the FBR of four microelectrodes with differing flexibility: silicon,
polyimide, OSTE+Hard, and OSTE+Soft. Youngs moduli of the three polymer probes
were obtained with dynamic mechanical thermal analysis. Then, an in vivo study
was conducted to quantitatively compare the FBR of the four types of probes at 4
and 8 weeks post-implantation (WPI). The CX3CR1-GFP mouse strain [124], widely
utilized in neuroscience research [125], was used to visualize microglia with endoge-
nous green fluorescence. In order to provide the structural rigidity for insertion into
mice pia mater, 4 kDa polyethylene glycol (PEG) was dip-coated onto probes.
4.3 Materials and methods
4.3.1 Fabrication of probes
As described in previous work [89, 120], OSTE+ is polymerized in two steps:
1) a fast UV initiated radical polymerization between a thiol and two allyls and
2) a slower thermal anionic polymerization between a residual thiol and an epoxy
resin. The first polymerization utilizes Irgacure(R) TPO-L (BASF, Germany), an
UV-initiator that crosslinks the thiol [tris(2-(3-mercaptopropionyloxy)ethyl] isocya-
nurate (BRUNO BOCK, Chemische Fabrik GmbH and Co. KG, Germany) with the
two allyls, trimethylolpropane diallyl ether and 2,4,6-triallyloxy-1,3,5-triazine. The
second polymerization utilizes DBN (1,5-diazabicyclo[4.3.0]non-5-ene) as the initiator
that crosslinks the unreacted thiol and the epoxy resin (D.E.N 341 Epoxy Novolac
resin, Dow Chemicals, USA).
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Table 4.1













OSTE+Hard 65% 1.65:(0.05:0.95):0.65 2000-3000 30 75
OSTE+Soft 20% 1.20:(0.95:0.05):0.20 500-1000 30-150 60
Thiol, allyls, and epoxy were mixed according to Table 1, with 0.2 wt% of DBN and
TPO-L. Triallyl and epoxy were preheated to 67 ◦C before mixing. After degassing,
the mixture was spin coated onto a silicon wafer having a 200 nm sacrificial layer of
titanium according to Table 1. Then, a 9 µm thick PVC film was applied to wafers
to prevent the mixture from sticking to the UV mask and from reacting with the
oxygen. Wafers were exposed to the UV light as listed in Table 1 using a MA4 mask
aligner (Carl Suss, Germany). Then, wafers were submerged in butyl acetate for
10-15 seconds to remove the PVC film and rinsed in toluene for 5 seconds. Wafers
were blown dry with nitrogen gas and placed in an oven at 67 ◦C for 2 days. Prior to
removing the sacrificial layer to release the probes, wafers were incubated in MilliQ
water at room temperature (RT) for 6 days. Wafers were blown dry and slightly etched
using an oxygen plasma etcher (Diener Femto, Germany) for 5 minutes in order to
remove a residual layer of OSTE+ left after the development. Probes were released
by incubating the wafers in 8% hydrofluoric acid solution for 24 hours. After rinsing
with MilliQ water several times the probes were released using a pair of tweezers.
Polyimide (Durimide 7520, FujiFilm, Belgium) was spin coated onto a titanium
coated (200 nm) silicon wafer at 1300 rpm for 60 seconds. Wafers were soft baked on
a hot plate at 100 ◦C for 3 minutes prior to UV-light exposure for 45 seconds. Wafers
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were allowed to rest overnight at RT. Then, wafers were developed using HTR-D2
(FujiFilm) for 4 minutes and rinsed with RER600 (FujiFilm). Wafers were blown dry,
hard baked in an oven at 180 ◦C for 2.5 hours, and submerged in MilliQ at RT for
6 days. Probes were released the same way as the OSTE+ probes using hydrofluoric
acid and MilliQ.
4.3.2 Fabrication of samples for dynamic mechanical thermal analysis
(DMTA)
For the dynamic mechanical thermal analysis (DMTA) testing, samples of each
polymer were made in blocks (1 mm thick, 10 mm wide, and 40 mm long). Samples
were submerged in MilliQ at RT for 6 days after the fabrication.
For OSTE+ block samples, thiol, allyls, and epoxy were mixed and degassed the
same way as the OSTE+ probe fabrication procedure. Then, the degassed mixture
was poured onto a PDMS mold, covered with a polycarbonate film, and exposed
to the UV-light for 40 minutes (using a Carl Suss MA4 mask aligner). After the
exposure, the polycarbonate film was removed and samples were demolded and hard
baked in an oven at 67 ◦C for 2 days.
For polyimide block samples, polyimide was poured onto a PDMS mold followed by
a soft-bake at 67 ◦C for 2 days. The amount of polyimide was adjusted accordingly to
compensate for the shrinkage. The mold was then exposed to UV-light for 40 minutes
(using a Carl Suss MA4 mask aligner) and samples were demolded and hard baked
in an oven at 180 ◦C overnight.
A dynamic mechanical analyzer (Q800, Texas Instruments, USA) was used to test
the Youngs moduli of the three polymer block samples. Tension was the mode of
deformation. Samples were tested from 5 ◦C to 45 ◦C with a 2 ◦C step size at a
frequency of 1 Hz. Three samples of each polymer were tested (N=3).
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4.3.3 In vivo implantation
One day before implantation surgery, four types of probes: silicon (GP1x16 249
(NeuroNexus Technologies, USA), 249 m wide, 15 m thick, 18◦ tapered tip), poly-
imide, OSTE+Hard and OSTE+Soft were autoclaved at 121
◦C for 30 minutes. All
probes were then dip-coated with sterilized 4 kDa poly-ethylene-glycol in an aseptic
settings and stored in a sterilized container until surgery.
All surgical procedures and animal care practices were performed in accordance
with the University of Florida Institutional Animal Care and Use Committee (IACUC).
Twenty-two adult mice, 20-24g, (B6.129P-Cx3cr1/J (Jackson Laboratories, USA),
N=5-6 per condition) were bilaterally implanted with one probe per hemisphere.
Mice were anesthetized with isoflurane (Abbott Laboratories, USA, 3% induction,
1.5% maintenance) and mounted onto a stereotactic frame. Mice were kept warm on
a heating pad and their vital signs were monitored using a pulse oximeter (MouseOx,
Kent Scientific, USA). After a small portion of scalp was removed, a craniotomy
was made on each hemisphere centered at 1.5 mm lateral and 1.5 mm posterior to
bregma. Probes were inserted 1.2 mm deep using a piezoelectric actuator (PILine
M-663, Physik Instruments, Germany) at 100 mm/s. Identifiable blood vessels were
avoided to minimize iatrogenic variability. Then, the upper portion of the probe was
trimmed with a pair of microscissors to detach from the actuator. Kwik-Sil (World
Precision Instruments, USA) was applied to the craniotomies and tethered the probes
followed by dental acrylic (Fusio Liquid Dentin, Pentron, USA) to secure the headcap.
4.3.4 Immunohistological staining
At 4 WPI or 8 WPI, mice were deeply anesthetized with 5% isoflurane and tran-
scardially perfused with 20 ml of cold phosphate buffered saline (PBS), followed by
20 ml of cold 4% paraformaldehyde solution (PFA) [46]. After post-fixing heads for
24 hours at 4 ◦C brains were carefully extracted while retaining the probes in place.
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Brains were cryopreserved in 30% sucrose in PBS at 4 ◦C for 24-48 hours. Then,
brains were flash frozen in 2-methyl-butane at -40 ◦C for 2 minutes and transferred
to a cryostat (CM1950, Leica, Germany). Brains were lightly embedded with Op-
timum Cutting Temperature (OCT) compound (Sakura Finetek, The Netherlands)
and sliced into 25 µm horizontal sections with the retained probes. Tissue slices were
collected on SuperFrost glass slides (Thermo Fisher, USA) and stored at 4 ◦C for the
immunostaining process.
Tissue slices were allowed to sit at RT for 30 minutes to adhere to the slides. After
washing for five minutes in PBS three times, tissue slices were blocked in blocking
buffer (4% v/v goat serum, 0.3% Triton-X in PBS) for two hours at RT. Primary
antibodies (refer to Table 2) were diluted in blocking buffer and applied to the slices
for incubation at 4 ◦C for 20-24 hours. Following primary incubation, slices were
washed for five minutes in PBS five times. Slices were then incubated in secondary
antibodies at RT for 2 hours. Following secondary incubation, slices were washed for
five minutes in PBS five times and cover-slipped using mounting medium (H-1000,
Vector Lab, USA).
Table 4.2
List of primary antibodies
Primary Antibodies Target of Interest
Anti-CD68 (1:250, ab53444, Abcam) Activated microglia/macrophages
GFP (Autofluorescent) Microglia/macrophages
Anti-IgG (1:250, ab150114, Abcam) Blood-brain barrier leakiness
Anti-GFAP (1:500, AB5541, Millipore) Astrocytes
Anti-NeuN (1:250, MABN140, Millipore) Neuronal nuclei
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Fluorescence images were taken with a laser scanning confocal microscope (LSM
710, Carl Zeiss, Germany). A 2x2 tile was captured using a 10X objective that
spans the device-tissue interface and its surroundings. For quantitative analysis, two
slices per sample, roughly from 400-600 µm down the cortical column, were used to
minimize the depth-dependent variability [46]. Qualitative figures presented in this
paper were contrast enhanced for visual clarification. For better identification of the
relationship between immunolabels, representative images are from the same animal
hemisphere, horizontal slices within 100 µm to each other.
MINUTE V1.5 was used for fluorescence intensity analysis [85,126,127]. An ellipse
was drawn to locate the contour of the device-tissue interface. Exclusion areas were
drawn to discard areas outside the cortical hemisphere of interest. For every 5 µm
concentric ring from the probe contour, average immunolabel intensities were com-
puted. Then a 5-tap moving Gaussian window was applied to smoothen the intensity
curves. All average intensities were normalized to the background, taken as the inter-
val 600-800 µm from the probe contour. Neuronal nuclei (NeuN) were automatically
counted using a custom built ImageJ [128] script.
Statistical analyses were performed using Prism 7.00 statistical analysis software
(GraphPad Software, USA). Integrated intensities were binned into 50 µm intervals
from 0 µm to 500 µm and averaged by each area. A two-way ANOVA was performed




The thickness of the polymer probes was measured using a microscope (Olympus
BX40, Sweden) with a height sensor. Measured thicknesses were: 21.3 ± 1.0 m
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(polyimide), 23.5 ± 2.1 m (OSTE+Hard), and 22.4 ± 2.1 m (OSTE+Soft) (mean ±
standard deviation, N=15). Probes were 250 m wide and 3 mm long with a tapered
tip of approximately 18 degrees in angle.
The thickness of the dip-coated PEG on the silicon probe was measured using
a profilometer (Alpha Step 500, Tencor, USA). The mean thickness of the thickest
portion was 46.05 ± 14.58 µm (mean ± standard deviation, N=9) on one side of the
broad surface.
4.4.2 Dynamic Mechanical Thermal Analysis (DMTA)
Fig. 4.1 shows mechanical properties of the three polymers compared to silicon
at given temperatures. Polyimide (1.5 GPa) was roughly three orders of magnitude
softer than silicon (˜150 GPa), approximately 5 times harder than OSTE+Hard (300
MPa) and approximately 250 times harder than OSTE+Soft (6 MPa) at 37
◦C. All
of the three polymers showed a decrease in Youngs modulus with an increase in
temperature. OSTE+Hard showed the largest decrease in Youngs modulus in the
tested temperature range. OSTE+Hard was softer than polyimide at 37
◦C but harder
at 20 ◦C. We see that the change in Youngs modulus of OSTE+ samples according
to the temperature were linear-quadratic in the logarithmic scale.
4.4.3 Activated microglia/macrophages (CD68)
CD68 is a glycoprotein present in monocyte derived immune cells, and is most
intensely expressed in their activated state [129]. Fig. 4.2 shows that, at 4 WPI,
silicon probes had significantly greater CD68 fluorescence intensity than the three
polymer probes in the 0-50 µm bin with the most dramatic difference within the
first 20 µm. At 8 WPI, silicon probes had significantly greater CD68 than polyimide
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Fig. 4.1. Mean Youngs moduli of silicon, polyimide, OSTE+Hard and
OSTE+Soft (A) as a function of the temperature and (B) at 20
◦C
and 37 ◦C (with ± standard deviation). The three polymer samples
were measured using a dynamic mechanical analyzer.
and OSTE+Hard probes in the 0-50 µm bin. Unlike 4 WPI, at 8 WPI the mean
intensity of CD68 around silicon probes was more dispersed and not as concentrated
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in the first 20 µm. The mean intensity generally decreased from 4 WPI to 8 WPI for
all types of probes, with the greatest decrease seen with silicon. The decrease was
most pronounced in the 0-50 µm bin whereas regions beyond 50 µm stayed relatively
consistent.
Fig. 4.2. Activated microglial/macrophage response (CD68) to im-
planted silicon, polyimide, OSTE+Hard, and OSTE+Soft probes. (A)
Representative CD68 fluorescent images at 4 WPI and 8 WPI. (B)-
(C) Normalized CD68 fluorescence intensity as a function of distance
with shaded standard error. Statistically significant differences were
found in the 0-50 µm bin (p<0.05) denoted by the solid line with
an asterisk. Inset in (C) is a magnification of the 0-100 µm interval.
Scale bar is 100 µm.
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4.4.4 All microglia/macrophages (GFP)
GFP is expressed in monocyte derived immune cells of CX3CR1-GFP transgenic
mice, labeling both activated and non-activated microglia/macrophages in the brain
[124]. In the 0-50 µm bin, silicon probes had significantly greater GFP intensity
than polyimide probes at 4 WPI, as well as all three polymer probes at 8 WPI.
GFP expression near all the probes was more amorphously aggregated than the outer
region where resting microglia are detected. By 100 µm there was no noticeable
difference in the distribution of microglia compared to regions beyond 500 µm. The
mean GFP fluorescence intensity generally decreased from 4 WPI to 8 WPI. Unlike
CD68, however, the decrease was minimal. CD68 was mostly co-localized with GFP,
but not vice versa.
4.4.5 BBB Leakage (IgG)
Immunoglobulin G (IgG) is the most abundant antibody in blood serum and is
often used in chronic inflammatory studies to indicate leakiness of the BBB in the
brain parenchyma [39]. In the 0-50 µm bin, silicon probes had significantly greater
IgG fluorescence intensity than OSTE+Hard probes at 4 WPI, as well as polyimide
and OSTE+Hard probes at 8 WPI. OSTE+Soft probes had significantly greater IgG
than polyimide and OSTE+Hard probes at 8 WPI in the 0-50 µm bin. Although the
mean IgG intensity of silicon probes was greater than OSTE+Soft probes at 8 WPI, no
statistical difference was found between the two types of probes. Large inter-animal
variabilities were observed within the same type probes, manifesting high standard
errors. This variability was especially notable around silicon probes at 8 WPI up to
100 µm from the implant. The trend of IgG generally corresponded with CD68 and
GFP in terms of silicon probes exhibiting the highest FBR than the other probes.
Unlike CD68, there was no notable change in the mean intensity at 8 WPI compared
to 4 WPI.
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Fig. 4.3. Microglial/macrophage response (GFP) to implanted sili-
con, polyimide, OSTE+Hard and OSTE+Soft probes. (A) Representa-
tive GFP fluorescent images at 4 WPI and 8 WPI. (B)-(C) Normalized
GFP fluorescence intensity as a function of distance with shaded stan-
dard error. Statistically significant differences were found in the 0-50
µm bin (p<0.05) denoted by the solid line with an asterisk. Scale bar
is 100 µm.
4.4.6 Astrocytes (GFAP)
Glial fibrillary acidic protein (GFAP) is an intermediate filament protein that
is expressed in mature astrocytes, and more intensely expressed in reactive astro-
cytes [36]. At 4 WPI, polyimide probes had significantly greater GFAP fluorescence
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Fig. 4.4. BBB leakiness (IgG) around implanted silicon, polyimide,
OSTE+Hard and OSTE+Soft probes. (A) Representative IgG fluo-
rescent images at 4 WPI and 8 WPI. (B)-(C) Normalized IgG flu-
orescence intensity as a function of distance with shaded standard
error. Statistically significant differences were found in the 0-50 µm
bin (p<0.05) denoted by the solid line with an asterisk. Scale bar is
100 µm.
intensity than OSTE+Hard probes in the 0-50 µm bin. At 8 WPI, silicon probes
had significantly greater GFAP intensity than OSTE+Soft probes in the 0-50 µm bin.
Mean GFAP intensity profile across probes types became more similar to each other
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at 8 WPI than at 4 WPI. At both times, GFAP intensity mostly dropped down to
the background level after 150 µm.
Fig. 4.5. Astrocytic response (GFAP) to implanted silicon, polyimide,
OSTE+Hard, and OSTE+Soft probes. (A) Representative GFAP flu-
orescent images at 4 WPI and 8 WPI. (B)-(C) Normalized GFAP
fluorescence intensity as a function of distance with shaded standard
error. Statistically significant differences were found in the 0-50 µm
bin (p<0.05) denoted by the solid line with an asterisk. Scale bar is
100 µm.
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4.4.7 Neuronal nuclei (NeuN) density
Neuronal nuclei were identified with the NeuN immunolabel. Although significant
differences were found with other inflammatory markers, no statistical significance
was found between any two types of probes at 4 WPI and 8 WPI. Mean neuronal
densities approached background levels from approximately 100 µm away from the
implant. Mean neuronal densities of silicon probe and polyimide probe were higher at
8 WPI than at 4 WPI in the 0-50 µm bin, although the differences were statistically
not significant. Mean background neuronal densities were 2894 ± 290 cells/mm2 (4
WPI) and 2493 ± 381 cells/mm2 (8 WPI) (mean ± standard deviation, N=11).
4.5 Discussion
Our work herein supports the notion that flexible probes are a favorable choice
for neural implants. There was a significant reduction in the mean intensities of FBR
markers surrounding the three polymer probes compared to silicon probes. However,
it appears that further increasing the flexibility beyond polyimide failed to attenuate
the FBR. The difference in Youngs modulus between silicon and polyimide, the stiffest
of the three polymers, was roughly 100 times. Although the difference in Youngs
modulus between the polyimide probe and OSTE+Soft probe was roughly 250 times,
we did not find any consistent statistical differences in the inflammatory markers
between the pairs of polyimide, OSTE+Hard, and OSTE+Soft probes. From this, we
infer that flexibility plays a critical role when the probe is relatively hard, but its
effect diminishes as the probe gets softer.
The three polymer probes generally showed a reduction in the FBR markers com-
pared to silicon probes. CD68 intensity indicated that there was a significantly more
persistent microglial and macrophage activation around silicon probes than the poly-
mer probes. We also found that there was a large reduction in CD68 intensity at 8
WPI than at 4 WPI for all types of probes. This corresponds with previous studies
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Fig. 4.6. Neuronal nuclei (NeuN) density near the implanted
probes. (A) Representative fluorescent images of silicon, polyimide,
OSTE+Hard and OSTE+Soft probes at 4 WPI and 8 WPI. (B)-(C)
Normalized neuronal density as a function of distance with standard
error. No statistically significant differences were found with Tukeys
pairwise comparison (p>0.05). Scale bar is 100 µm.
that showed consistent reduction in microglial/macrophage activation after 2 WPI
up to 16 WPI [28, 85]. GFP also pointed toward the same conclusion that silicon
probes induced the most intense microglial/macrophage response. The overall trend
at 4 WPI and 8 WPI both suggest that CD68 and GFP responses were most intense
around silicon probes, despite small variations in the type of probes being significantly
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different vs. silicon probes. A region with high CD68 response always accompanied
GFP response. However, their relative intensities did not exactly match. It has
been reported that a higher-level GFP expression was observed in monocyte-derived
macrophages of CD68-GFP mice compared to CX3CR1-GFP mice [130]. It infers a
preferential expression of CD68 in myeloid lineage cells and GFP in brain-resident
microglia, although GFP is also weakly expressed where CD68 is expressed. With
this inherent difference, consistency observed with CD68 and GFP intensity in our
study strengthens the statistical significance found in immune cell distribution.
Similar to CD68 and GFP, IgG intensity indicated that silicon probes induced the
most severe chronic BBB leakage. However, OSTE+Soft also had significantly higher
IgG intensity compared to the other two polymer probes at 8 WPI. As OSTE+Soft only
differed with OSTE+Hard in the constituent mixing ratio and the resulting softness, it
is unlikely that OSTE+Soft probes chemically or physically perturb BBB more than
OSTE+Hard probes. It is possible that localized IgGs seen only around the probes,
within the tight astroglial junction, depends more on the insertion injury and less on
the chronic BBB leakage [131]. Note that in general, IgG was particularly variable
among the inflammatory markers used in this study. Even among the silicon probes
only a few exhibited a very high IgG response near the probe (i.e., 2/5 at 4 WPI
and 1/5 at 8 WPI, more than twice greater than the median), rendering the overall
mean high. This implies that there may be an important contributor to the FBR
other than the extent of the tissue damage, such as the existence or nonexistence of
vasculature near the probe. It is speculated that the BBB integrity depends on the
chance of mechanical/biochemical damage to nearby large blood vessels, with stiffer
probes having a higher incidence of damage. Depending on the location, stiffer probes
may not compromise the BBB severely, as seen from the subset of silicon probes in
this study that did not show an intense IgG level. However, a joint characterization of
IgG with vasculature will help to confirm that the degree of IgG response is correlated
to nearby vessels.
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Unlike CD68, GFP, and IgG, silicon probes did not demonstrate more severe in-
flammation than the polymer probes in the context of GFAP and NeuN responses.
We expected to see a decrease in GFAP intensity and an increase in neuronal density
around the polymer probes, as studies suggest an inverse relationship of neuronal
density to astrocytic scar, microglial activation, and BBB integrity in the chronic
phase [101,132,133]. Along with the statistics, however, representative images of im-
munolabels that are approximately from the same region also suggested that probes
with high CD68, GFP, and IgG did not always exhibit a significant astrogliosis or
decrease in neuronal density. It should be noted that discrepancies among studies
evaluating flexible probes [84, 85] indicate that differences in surgery, immunohistol-
ogy, imaging, and analysis methods can impact the results more significantly than
flexibility. Moreover, aforementioned studies were conducted in rats. Although not
dramatically different from rats, mice are reported to show more prolonged astro-
cytic activation and higher neuronal density around implanted probes [126]. Taken
together, previous studies are not directly comparable and discrepancies observed in
this study need to be considered in their own context.
With GFAP intensity, there were significant differences between OSTE+Hard probes
and polyimide probes at 4 WPI, and between silicon probes and OSTE+Soft probes
at 8 WPI. However, these were inconsistent across the two time points and across the
other immunolabels. With NeuN, no statistically significant differences in neuronal
density were observed with any pair of probes at either time point. Although not
statistically significant, neuronal densities at 8 WPI were generally higher than 4
WPI in the 0-50 µm. This is in line with previous findings that neurons around an
implanted device exhibit a multi-phasic response over time [25,28,84], the mechanism
of which is yet to be understood as recording/stimulation performance typically does
not recover at later time points. It is worth pointing out that with OSTE+Hard and
OSTE+Soft probes we did not observe such come back of neurons at 8 WPI. However,
it is unlikely that this is a phenomenon pertaining to OSTE+ probes since there was
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no indication of OSTE+ being neurotoxic from the results of inflammatory markers.
A cytotoxicity assay (MTT assay) in our previous study confirmed that OSTE+
samples were non-toxic after a sufficient incubation in MilliQ water [89]. The size
of the OSTE+ samples used in the MTT assay were 1 mm thick, roughly 45 times
thicker than OSTE+ probes. Based on simple diffusion, unreacted constituents in the
22 µm thick probe would be eliminated quicker than those in the 1 mm thick sample.
This suggest that OSTE+ probes are unlikely to chemically induce inflammation.
Surface topology was also not a critical concern, as identified in our previous work
with scanning electron microscope (SEM) showing smoothly constructed hydrophobic
surfaces of OSTE+ samples [89].
We preserved the probes within the tissue during the entire procedure. This mainly
prevented tissue distortion during device extraction and allowed us to image the
device-tissue interface more precisely. A drawback was that silicon devices mostly
shattered while cryosectioning; however, it did not severely alter the interface as
seen in the figures. Reflected fluorescence from the polymer probes was detected,
with polyimide being the brightest followed by OSTE+Soft. This fluorescence further
confirmed the precise location of the device. As a fluorescing device could interfere
with our quantitative analysis, we took a conservative approach on the images to
remove the device track prior to performing MINUTE analysis. Interestingly, we did
not find any tissue slices with a hole that is far larger than the size of the device,
which makes it hard to define the device contour for quantitative analysis.
A devices flexibility depends on both the dimension and softness (i.e., Youngs
modulus). In our study silicon probes were 15 µm thick and the three soft polymer
probes were approximately 22 µm thick. As smaller probes are favorable in reduc-
ing the FBR as well as enhancing recording functionality [58], silicon devices were
expected to cause a less severe FBR than the polymer probes if size was the sole
variable. The difference of 7 µm in thickness means that silicon probes used in this
study were softer (i.e., roughly 3 times in the planar direction (153: 223 ∼= 1:3) and 1.5
58
times in the lateral direction (15: 22 ∼= 1:1.5)) than the silicon probe with the same
thickness as the polymer probes. Although silicon probes were thinner they induced
the most severe FBR of the four types of probes, as indicated by CD68, GFP, and IgG
intensities. The impact of stiffness of silicon probes likely overshadowed the benefit
of small size. A simple dip-coating in PEG was chosen as the stiffening method for
insertion of the polymer probes. Our initial test on a 0.85% agarose gel block revealed
that OSTE+Hard and OSTE+Soft probes always buckled, and polyimide probes buck-
led by chance (8 out of 10 buckled). Dip-coating with 4 kDa PEG provided sufficient
structural rigidity for penetration for the polymer probes. Inserting at a very high
speed (100 mm/s) also helped the probes penetrate before the PEG dissolved in the
cerebrospinal fluid. Higher insertion speeds have been reported to be beneficial in
minimizing the shear force [61,134] and this may have helped in minimizing the over-
all level of FBR in our study. No evidence of flexible probe deformation was found
as probe shape and location along the depth (0-900 µm) were stable regardless of the
probe type (data not shown). Note that silicon probes were also coated to prevent
PEG-coating from confounding the study.
The fact that OSTE+ probes did not significantly reduce the FBR over poly-
imide probes suggest a threshold model for flexibility. This is further supported by
OSTE+Soft probes not reducing the FBR over OSTE+Hard probes, negating the con-
cern of comparing different materials. More evidence is required to conclude that the
degree of FBR does not decrease with a material softer than OSTE+Soft. As depicted
in Fig. 4.7, however, it is reasonable to speculate that the impact of flexibility in
reducing the FBR would continue to diminish with increasing flexibility. A materials
Youngs modulus does not have to be as low as the interacting material to prevent
generating significant strain stress as long as the material is sufficiently thin. Since
the probes in this study were 15-22 µm thick, the results pertain to probes in this
range of thickness, as well as other design parameters. Species and organ type can
also affect the outcome as tissues have different softness and this can influence their
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Fig. 4.7. An illustrative graph showing hypothetical saturation of the
impact of flexibility to the FBR.
tolerance level to the implant stiffness. It should also be noted that dummy devices
used in this study were tethered to the silicon elastomer. If the device had a rigid
wiring backbone, it can strengthen the degree of tetheredness to the skull and is
another variable to be considered.
Resolving the biological tissue response to neural implants requires a multi-dimensional
approach [103]. This includes flexibility, dimension, architecture, tethering to the
skull, tissue integration, insertion profile, bioactive coatings, and drug release. One
or more of these can be the limiting factor that dictates the eventual tissue response
regardless of improvements in other aspects. Thus, we envision that the “threshold
effect, i.e. performance limits from softer devices, can be overcome once other factors
are improved. Improving the biggest pitfall step by step will be key to advancing the
lifetime of neural implants.
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4.6 Conclusion
We have investigated the biological impact of flexibility on the FBR by using four
types of probes with different Youngs moduli: silicon, polyimide, OSTE+Hard and
OSTE+Soft. A quantitative assessment of inflammatory biomarkers suggest that sili-
con probes induced the most severe FBR compared to the three soft polymer probes.
No consistent statistical differences were found among the polymer probes, indicat-
ing that further increasing the probe flexibility beyond polyimide did not reduce the
FBR. This suggest a possible threshold model for flexibility.
We believe OSTE+ probes are still a valuable addition to implantable electrode
fabrication and designs as they performed no worse than polyimide probes. The
tunable glass transition property and easy patternable nature of OSTE+ polymers
can make them more useful over polydimethylsiloxane (PDMS), which is similarly
soft to OSTE+Soft.
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5. TISSUE RESPONSES TO NEURAL IMPLANTS
DIP-COATED WITH POLYETHYLENE GLYCOL (PEG)
5.1 Abstract
Objective: Polyethylene glycol (PEG) and the CX3CR1-GFP transgenic mouse
model are frequently used tools in neural implant studies. We have evaluated the
biological implications of using PEG and CX3CR1-GFP mice for chronic neural im-
plants. Methods: Mice (CX3CR1-GFP and wild-type (WT)) received bilateral im-
plants within the sensorimotor cortex, one hemisphere with a PEG-coated probe
and the other with a non-coated probe for four weeks. Quantitative analyses were
performed using biomarkers for activated microglia/macrophages, astrocytes, blood-
brain barrier leakage, and neuronal nuclei to determine the degree of foreign body
response (FBR) resulting from the implanted microelectrodes. Results: We observed
that PEG prevented glial cell adsorption to the device, however, PEG-coated devices
caused no significantly different FBR compared to non-coated controls. Likewise,
the genetically modified CX3CR1-GFP mouse model did not exhibit any significant
statistical difference compared to WT mice. Conclusion: We conclude that PEG-
coatings and the CX3CR1-GFP mouse model do not have significant impact on the
FBR. Thus, they are valid tools for chronic neural implant studies that do not bias
the outcomes. Significance: Our results benefit former and ongoing neural implant
research utilizing PEG and/or CX3CR1-GFP mice by resolving supposed pitfalls and
confirming their limited role in ameliorating or exacerbating the FBR.
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5.2 Introduction
Implantable neural probes hold the promise of providing functional recovery of
various symptoms associated with traumatic injuries or neurological disorders [1, 2].
A major dilemma of using such devices is that their functionality degrades over
time, which eventually leads to the inability of discriminating relevant neural sig-
nals from background noise [20, 31, 135]. In an attempt to resolve the biological
aspects of this issue, researchers have modulated multiple factors including: device
architecture/material type [58, 62], bioactive coatings [136–139], and drug delivery
schemes [140, 141]. In parallel to these engineering mitigation strategies [103], there
are ongoing attempts to discover the precise biotic and abiotic mechanisms of im-
plant failure in order to develop strategies to improve the functional lifetime of neural
implants [100].
One of the most common and indirect methods for evaluating the effectiveness of
these intervention strategies is looking at markers of the FBR. Typically, implanted
microelectrodes in the brain instigate a neuro-inflammatory cascade that involves
infiltration of plasma proteins, monocytes, macrophages and leukocytes from breached
blood-brain barrier (BBB), activation and recruitment of microglia and macrophages
to the injury site, activation of astrocytes to initiate astrogliosis, and a loss of neurons
near the implant [19, 22, 43, 102, 126]. A severe FBR generally results in a large
neuronal loss in the long-term [127,142]. Thus, reducing the FBR has been considered
essential to achieve long-term functionality of neural implants.
A number of neural-interface strategies have used the inorganic, biocompatible
polymer polyethylene glycol (PEG). Examples include using PEG as an adhesive
for aid in insertion [108], a stiffening agent for inserting flexible probes [143, 144],
or as a vector for molecules to deter protein adsorption [137, 138]. While the exact
mechanisms are unknown, there are studies suggesting the use of PEG as a standalone
treatment for spinal cord injury (SCI) [145, 146], traumatic brain injury (TBI) [147,
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148], and peripheral nerve damage [149]. It was reported that PEG reduces oxidative
stress and repairs damaged cell membranes which contribute to enhanced anatomical
and functional recovery over a few hours [146–148] to weeks or months [145, 149].
However, the explicit consequence of using PEG for brain-implanted microelectrodes
has not been investigated. This is a potential confound of neural-interface studies
that utilize PEG as an insertion or stiffening aid.
There has been an ongoing effort to interrogate the cellular dynamics underlying
the neuro-inflammatory cascade in response to brain injuries [150]. Transgenic mouse
models expressing fluorophores in specific cell types in conjunction with fluorescence
imaging techniques have proven invaluable for this purpose. CX3CR1-GFP mice ex-
press green fluorescent protein (GFP) in immune cells including microglia [124]. This
strain has been actively used in studies investigating the progression of microglial
response to implants, particularly during acute time points [125,151]. Since microglia
are one of the first responders to foreign objects within the brain, investigating their
morphological states, from resting to activated, has provided insight into the cellular
dynamics of the FBR onset. Moreover, transgenic mouse models alleviate the need
for immunohistological processing and provide consistency in fluorescence intensity.
However, it is important to consider the effects that genetic manipulation may have
upon CX3CR1-GFP mice. Loss of the fractalkine receptor may alter microglial be-
havior to a neural implant, leading to an altered inflammatory cascade. Knowing if
CX3CR1-GFP transgenic mice produce a similar FBR to WT mice is necessary for
neural implant studies utilizing CX3CR1-GFP mice.
In this paper, we evaluated the biological response to PEG-coated silicon probes and
non-coated silicon probes in two different mouse strains: CX3CR1-GFP (B6.129P-
CX3CR1-/-) and WT (C57BL/6). 4 kDa PEG was chosen for its superior anti-
biofouling property [152]. Statistical tests on the biomarkers of FBR were performed
with both independent comparisons and paired comparisons. Furthermore, the cor-
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relation between biomarkers was calculated to address possible direct and indirect
relationship between the components of the FBR.
5.3 Materials and methods
5.3.1 Probe preparation and PEG-coating
Planar Michigan type silicon microelectrodes, 249 µm wide and 15 µm thick, were
used in this study (GP 1x16 249, NeuroNexus, Ann Arbor, MI; also used in [107]).
Probes and PEG (4 kDa MW, Sigma, St. Louis, MO) were autoclaved for 30 min
at 120 ◦C one day prior to surgery. In an aseptic setting, PEG was melted on a hot
plate at 80 ◦C and the probes were dip coated in PEG for 5 seconds (Fig 5.1). After
allowing the probes to air dry they were sealed in a sterilized container until surgery.
A separate set of probes coated with PEG were taken for profilometry thickness
measurements (Alpha Step 500, Tencor, Milipitas, CA). The thickness of the PEG-
coatings was 46.05 µm (±4.86 µm, s.e.m., N=9) on one side of the broad surface.
Images of non-coated and PEG-coated probes are depicted in Fig. 4.1 (A)-(B).
5.3.2 Surgical implantation
All surgeries and animal experiments were performed in accordance with the Uni-
versity of Florida Institutional Animal Care and Use Committee (IACUC) guidelines.
Briefly, 2-3 months old (18-28 g) WT mice (C57BL/6, N=4) and CX3CR1-GFP
mice (B6.129P-CX3CR1-/-, Jackson Laboratories, Bar Harbor, ME, N=4) were bi-
laterally implanted with a PEG-coated device in one hemisphere and a non-coated
device in the other hemisphere. Mice were anesthetized with isoflurane (3% induction,
1.5% maintenance) and kept warm using a heating pad. Vital signs were monitored
throughout the surgery with a pulse oximeter (MouseOx, Kent Scientific, Torrington,
CT). After a small portion of scalp was removed, a craniotomy above each brain hemi-
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sphere was performed using a microdrill. A probe was mounted onto a piezoelectric
actuator (PiLine M-663, Physik Instruments, Karlsruhe, Germany) and inserted into
one hemisphere 1.2 mm from the cortical surface at 100 mm/s. Sensorimotor cortical
regions (approximately 1 mm posterior and 1.5 mm lateral to bregma) were targeted,
however small deviations occurred to avoid large surface vasculature. This procedure
was then repeated on the contralateral hemisphere. After the insertion in both hemi-
spheres, craniotomies were covered with silicone elastomer (Kwik-Sil, WPI, Sarasota,
FL) followed by dental acrylic (Fusio Liquid Dentin, Pentron, Orange, CA) to secure
the devices. Post-operative care involved applying antibiotic ointment (Actavis, NC)
around the cut areas and maintaining the body temperature. Meloxicam (Norbrook,
United Kingdom) was administered pre- and up to three days post-surgery to alleviate
pain.
Fig. 5.1. (A) Planar silicon probe GP 1x16 249 used in this study.
(B) Probe dip-coated with PEG. (C) An image from a typical tis-
sue slice demonstrating using Minute v1.5 for quantitative analysis
of immunolabels. Yellow dotted concentric circles denote binned in-
terval (0-50 µm, 50-100 µm, 100-200 µm, and 200-300 µm from the
defined probe contour). GFP (green), GFAP (red), and NeuN (blue)
are shown. Outside the red dashed circle (600 µm) was considered




After four weeks of implantation, mice were deeply anesthetized with 5% isoflurane
and transcardially perfused with 20 mL of ice cold phosphate buffered saline (PBS, pH
7.4) followed by 20 mL of ice cold 4% paraformaldehyde (PFA, pH 7.4) solution. Heads
were then isolated and soaked in 4% PFA for 24 hrs at 4 ◦C for post-fixation. After
rinsing with PBS, brains were carefully extracted from the head and cryopreserved in
30% sucrose in PBS for 24-48 hrs at 4 ◦C. Brain tissues were flash frozen in 2-methyl
butane at -40 ◦C for 2 min and equilibrated to -20C before cryosectioning. Tissues
were lightly embedded with Optimal Cutting Temperature (OCT) medium (Sakura
Finetek, Alphen aan den Rijn, The Netherlands) then sectioned into 25 µm slices
and transferred to electrostatic adhesive glass slides (Superfrost Plus, Thermo Fisher
Scientific, Waltham, MA). Harvested slices were kept at 4 ◦C for no longer than one
week before immunolabeling.
5.3.4 Immunohistological staining
Tissue slices were allowed to sit at room temperature (RT) for 30 min for secure
adhesion onto slides. Tissue slices were rinsed three times with PBS for 5 min each
to remove residual OCT and then blocked in blocking buffer (4% goat serum, 0.3%
Triton-X in PBS) for 2 hrs at RT. Primary antibodies diluted in blocking buffer were
applied and incubated for 20-24 hrs at 4 ◦C. Following primary incubation, tissue slices
were washed five times with PBS for 5 min each to remove any unbound primaries.
Corresponding secondary antibodies diluted in blocking buffer were then applied to
the tissue slices and incubated for 2 hrs at RT. After 5 min of five subsequent washes
with PBS, tissue slides were cover slipped using VectaShield mounting medium (H-
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(1:500, A21071, Life Tech.)
Neuronal nuclei
5.3.5 Imaging and quantitative analysis
Fluorescence images were taken with a Zeiss LSM 710 laser scanning confocal mi-
croscope (Carl Zeiss, Jena, Germany). A 2x2 tile was captured using a 10X objective
to obtain a wider view of the device-tissue interface for quantitative analysis. To
minimize the depth dependent variability [46], two slices per sample, roughly from
450-600 µm down the cortical column, were used for quantitative analysis. A 20X
objective was used for representative qualitative figures. A maximum intensity pro-
jection was used for 20X stacks to span 10 µm. Qualitative figures presented in this
paper were contrast enhanced for visual clarification.
We used Minute v1.5 [126, 127] for quantitative analysis. Briefly, an ellipse was
drawn to define the contour of the device track. Exclusion areas were drawn to
limit analysis to be conducted on only artifact-free areas in the device-containing
hemisphere. For each 5 µm concentric ring, expanding from the defined ellipse, the
average label intensity and the area of the ring was calculated. The strength of
Minute V1.5 is that it allows us to utilize the entirety of an image, which is useful for
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reducing potential bias from using only a portion of the image for quantification. An
illustration is depicted in Fig. 5.1 (C).
We binned in intervals: 0-50 µm, 50-100 µm, 100-200 µm, 200-300 µm, and 300-500
µm. Average intensities of 5 µm rings were weighted by each area over the total area
and summed to generate an average intensity of each binned interval. Each average
binned interval was normalized to background, taken as the ring 600-800 µm away
from the device contour. Neuronal nuclei (NeuN) were counted with ImageJ [128]
using a custom, automated cell counting script.
5.3.6 Statistical analysis
Statistical analyses were performed using Prism 7.00 statistical analysis software
(GraphPad Software, La Jolla, CA). A two-way ANOVA was made taking strain (GFP
vs. WT) and coating scheme (PEG-coat vs. no-coat) as the independent variables
for the test at each binned interval. Post-hoc Tukeys test was also performed to
identify which two conditions made the most significant difference among the four
treatments. Then, we blocked each animal to eliminate inter-animal variability and
ran paired t-tests to directly compare a PEG-coated device implanted hemisphere
with its contralateral non-coated device implanted hemisphere.
5.3.7 Correlation coefficient
To further assess the dependencies between immunolabels, we calculated Pearson
correlation coefficient of normalized fluorescence intensities. The correlation coeffi-
cient was defined as
CorrCoef =
E [(L1 −mL1) (L2 −mL2)]
σL1σL2
(5.1)
where L1 and L2 are vectors representing normalized intensities of immunolabels
of interest over the binned intervals, mLk is the mean of Lk, σLk is the standard




To identify whether observed immune responses correspond with previously pub-
lished work [22,125] we took high magnification images of microglia in the proximity
of the implant to examine their morphology. Fig. 5.2 (A) shows CD68, GFP, and
merged images of a device-tissue interface taken with a 20X objective. It can be seen
in Fig. 5.2 (A)-(D) that activated microglia/macrophages extended their processes
toward the implant track (C) and/or fused together making them harder to detect as
individual cells (D). They looked largely different from ramified microglia that are in
a resting state (B). This microglial activity was also identified by co-localization of
GFP with CD68 immunoreactivity. Of the microglia co-localized with CD68 near the
implant track, no particular morphological differences were noted between PEG-coat
and no-coat groups (data not shown).
Fig. 5.2 (E) and (F) are examples of microglial adsorption to PEG-coated and non-
coated devices, respectively. After four weeks less microglia adhered to PEG-coated
devices than non-coated devices. It appeared that microglia did not preferentially
adhere to a specific region such as electrode sites.
5.4.2 Quantitative analysis of immunolabels
Quantitative analysis of normalized CD68 fluorescence intensity vs. distance from
the implant is depicted in Fig. 5.3 (A) and (C). CD68 was strongest in the 0-50 µm
interval and gradually decreased to the background level in the outer regions. No
statistical significance was found between CX3CR1-GFP vs. WT and PEG-coat vs.
no-coat at any given interval (p>0.05). There was no significant interaction effect
between the coating and animal strain (p>0.05). A paired t-test, conducted to solely
compare the effect of PEG-coating, also did not indicate any statistical difference
(p>0.05).
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Fig. 5.2. (A) CD68 fluorescence, autofluorescent GFP, and a merged
image of a CX3CR1-GFP non-coated device-tissue interface at four
weeks. The solid circle highlights non-activated, ramified microglia
that do not co-localize with CD68 (high-magnification image shown
in (B)). The dashed circle highlights activated microglia that are
extending their processes toward the implant (high-magnification
image shown in (C)). The dotted circle highlights highly acti-
vated microglia/macrophages that look to be lumped together (high-
magnification image shown in (D)). Autofluorescent GFP of (E) an
extracted PEG-coated probe and (F) a non-coated probe. Scale bars
in (A) and (E) are 100 µm and (B) is 20 µm.
In Fig. 5.3 (B), we see that the mean IgG fluorescence intensity was generally
greater for WT than CX3CR1-GFP, especially in the 0-50 µm and 50-100 µm in-
tervals. However, the difference between CX3CR1-GFP and WT was not significant
(p>0.05) and inconsistent with other immunolabels which showed an opposite mean
trend to what was observed with IgG (e.g., CD68 being higher for CX3CR1-GFP
than WT). IgG was particularly variable in contrast to other immunolabels used in
this study, as is indicated by high standard error of the means.
No statistical difference in normalized GFAP fluorescence intensity was found be-
tween PEG-coat vs. no-coat and CX3CR1-GFP vs. WT with independent two-way
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ANOVA or paired t-test, as can be seen in Fig. 5.4 (A). The mean values of GFAP
were stable especially at 0-50 µm regardless of the treatment type, indicated by rel-
atively small error bars than that of other immunolabels. Fig. 5.4 (C) shows that
there was no statistical difference in the neuronal density between PEG-coat and
no-coat. The neuronal density at 0-50 µm was highly variable but gradually became
stable at distant intervals. The background neuronal densities were 2347 (±94, s.e.m.,
N=8) cells/mm2 for GFP mice and 2376 (±53, s.e.m., N=8) cells/mm2 for WT mice,
which are in the range of previously reported neuronal densities in healthy mouse
cortex [153].
Fig. 5.3. Normalized fluorescence intensity of (A) CD68 and (B) IgG
as a function of distance from the implant at four weeks. p-values of
the two-way ANOVA and paired t-test of (C) CD68 and (D) IgG for
each binned interval. Error bars denote standard error mean (N=4).
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Fig. 5.4. Normalized fluorescence intensity of (A) GFAP and (B)
neuronal density as a function of distance from the implant at four
weeks. p-values of the two-way ANOVA and paired t-test of (C) GFAP
and (D) NeuN for each binned interval. Error bars denote standard
error mean (N=4).
5.4.3 Variability of FBR
Even within the same treatment groups vastly different tissue responses were
observed. PEG-coated or non-coated devices, regardless of implanted in CX3CR1-
GFP mice or WT mice, caused either a mild response or a severe response, as can be
seen in Fig. 5.5. In mild responses, CD68, IgG, and GFAP fluorescence intensities
were relatively weaker and only localized to the implant track. In severe responses,
the fluorescence intensities were stronger and largely diffused to the outer intervals.
Mild responses were also manifested by a relatively high neuronal density near the
implant track than that of severe responses. When there was a large implant track,
it always accompanied a severe response. However, a severe response did not always
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indicate that its implant track was large (e.g., in Fig. 5.5 CX3CR1-GFP PEG-coat
severe response).
Fig. 5.5. Representative images of CD68, IgG, GFAP, and NeuN
immunolabels in GFP mice and WT mice that show either a mild or
a severe FBR. Images in the same column are from the same animal.
Scale bars are 100 µm.
5.5 Discussion
5.5.1 Microglial morphology and adsorption to the device
As described in a number of reports, activated microglia play a key role in the
neuro-inflammatory response to foreign objects by secreting various pro-inflammatory
and cytotoxic factors which propagate the neuro-inflammatory cascade [125,150]. We
see in Fig. 5.2 (A)-(D) that our samples reflect morphologic changes upon activation
that have been well established in this field. Kozai et al. showed that microglia,
presumably surveying the local environment, extend their processes toward the foreign
object at the onset of the phagocytic state [125]. Microglia then migrate toward the
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device surface and create a microglial sheath. We saw the extension of processes at
four weeks post-implantation, indicating that there was ongoing inflammation near
the implant track. The GFP in Fig. 5.2 (D), which highly co-localizes with CD68
activity, indicated maximally activated microglia or macrophages. It was unclear to
differentiate between microglia and macrophages as the GFP is expressed not only in
microglia but also in other monocyte derived immune cells [124].
Previous acute studies have revealed that PEG prevents protein adsorption to sil-
icon or polymer based probes by creating a hydrophilic layer in between the device-
tissue interface [137, 154, 155]. We also observed PEG-coated devices with fewer
microglia on their surface after four weeks of implantation (Fig. 5.2 (E)-(F)). This
infers that prevention of their processes from adhering to the probe in the initial
phase may affect their attachment in the long-term as well. An in vitro study by
Gutowski et al. showed that microglia are seldom found on PEG-decorated devices
at 24 hours post-implantation. Unlike their study, we observed microglial adherence
to PEG-coated devices at four weeks, likely established after the PEG layer dissolved
away. Also suggested by previous studies [132], attachment of microglia on hydropho-
bic devices necessitates care while quantitatively examining the device-tissue interface
after device extraction.
Investigating the GFP provides insights to the dynamics of microglia as well as
the entire inflammatory cascade. In a statistical study, however, quantifying more
specific microglial-activity markers, such as CD68 or CD11, refines our analyses by
excluding resting microglia signatures which may obscure the inflammation topology.
5.5.2 Effect of PEG-coating and CX3CR1-GFP mouse model
Conflicting expectations may exist regarding the use of PEG coatings. It could
be that 1) a larger implant track caused by the thick layer of coating exacerbate the
chronic FBR, or 2) PEG have an ameliorative effect on the FBR. For CX3CR1-GFP
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mice, the involvement of CX3CR1 gene in accelerating or decelerating the secretion
of neurotoxic factors in microglia is controversial.
PEG has been shown to be biocompatible and provide a beneficial effect on trau-
matic injury sites. PEG is not readily degraded upon hydration and interacts with
the surrounding tissues until it dissolves away [156]. Studies have reported that PEG
reconstitutes damaged cell membranes which in turn promotes axonal regeneration
in injured spinal cords [145, 146] or reduces traumatic or ischemic cell loss in the
brain [147, 148]. Moreover, acute in vivo/in vitro tissue responses [137, 155] and
impedance measurements [154] suggest that PEG possesses anti-biofouling properties
which prevent glial cell adsorption. The hydrated PEG layer can also work as a short
term diffusion barrier. Despite these reported beneficial roles of PEG no significant
difference was found for the immunolabeling of the FBR vs. no-coat in this study. It
is unclear whether PEG has little effect on reducing the FBR, or the beneficial effects
of PEG were leveled off by a larger initial trauma caused by the thick coating. The in-
crease in thickness of the penetrating profile was from 15 µm to ˜100 µm, which could
be sufficiently large to induce a difference when the thickness was retained through-
out the implantation period [58]. In our study, however, the thickness of the residing
material was kept the same as control since the PEG layer likely dissolves away upon
contact with the blood and cerebrospinal fluid. Skousen et al. found that the surface
area of the residing material is a significant factor when penetrating profiles are kept
similar [114]. Although we did not observe any significant difference with differing
penetrating profiles of PEG-coat vs. no-coat, we cannot single out the detrimental
effect of a thick penetration profile since the dissolved PEG may also influence the
surroundings.
CX3CR1, a receptor present in microglia, interacts with the ligand fractalkine in
neurons which is considered a mechanism of neuron-glia crosstalk. This poses the
question of whether the deletion of CX3CR1 has a prominent impact on the various
cells including neurons. Jung et al. found that the absence of CX3CR1 in microglia
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did not alter the microglial response to various inflammation models, one being a
peripheral nerve axotomy [124]. However, contradictory results were also reported
that CX3CR1 deletion may have a negative or positive effect on neurons. Cardona et
al. demonstrated that CX3CR1 deficient mice either stimulated with lipopolysaccha-
ride (LPS), given neurotoxins to induce Parkinsons disease symptoms, or genetically
modified to induce amyotrophic lateral sclerosis resulted in more neurodegeneration
than controls [157]. By contrast, Denes et al. and Donnell et al. reported that the
lack of CX3CR1 had a neuroprotective effect in brain ischemia and spinal cord injury
models, respectively [158,159]. Among these, our results corresponded well with Jung
et al. in which there was no significant impact with CX3CR1 deletion. It may be
that there is no general rule for CX3CR1 deficient microglia to react to the induced
inflammation, but rather the response largely depends on the type of stimuli and the
target region of the body.
In general, the acute phase of the FBR lasts up to 1-2 weeks and the chronic phase
begins around 3-4 weeks post-implantation. During the chronic phase there are less
dynamic cellular changes and the FBR persists as long as a foreign device remains
[19, 102]. The FBR among the studied conditions were not significantly different at
four weeks. Since it is well known that the degree of the FBR of control condition
(i.e., non-coated silicon device in a WT mouse) remains unchanged chronically, we
expect the FBR of other conditions to remain similarly beyond four weeks.
Even if PEG-coating and/or the CX3CR1-GFP mouse model caused small dif-
ferences in the FBR, the differences were not prominent compared to the innate
variability of the neural implant with the current technological standard. The qual-
itative images in Fig. 5.5 are indicative of the highly variable nature of the FBR
to implants. Even though all the surgical and care plans remained the same, there
was a large difference in the tissue response within the same group. This is in line
with the discrepancies observed from between studies or even within studies [102].
Rousche et al. and Williams et al. showed that a large variability existed even be-
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tween different shanks within a multi-shank device [30, 31]. Vascular damage can be
the most probable suspect for inducing this variability, as devices that sever large
vasculature have been reported to cause more severe neuro-inflammation [114, 133].
Although surface vasculature can be avoided during implantation, vasculature that
underlie brain parenchyma are hard to avoid unless identified. Emerging technologies
such as utilizing 3D mapping of the brain prior to insertion may minimize the BBB
damage [160]. Although the breach of the BBB is inevitable, reducing this variability
will be critical in facilitating quantitative research.
5.5.3 Correlation between immunolabels
Fig. 5.6 shows Pearson correlation coefficients of normalized immunolabel inten-
sities along the distance from the implant averaged across the animals. For NeuN, we
used the inverse of neuronal density since neuronal density is inversely proportional
to other inflammatory markers along the distance. Fig. 5.6 implies that dispersion
profiles of GFAP, NeuN-1, IgG, and CD68 are generally correlated to each other.
However, we see that NeuN-1 is relatively loosely correlated to other labels. This
suggests why histology is not always a strong predictor of the quality of the neural
recordings. A number of studies have failed to establish a direct correlation between
neuro-inflammatory markers and recording quality. As neurons are the most impor-
tant cells that are directly related to the quality of neural recordings, it is likely that
the unpredictable neuronal density is the root cause of this discrepancy.
The correlation coefficient of IgG and CD68 were predominantly higher than the
other pairs from the four immunolabels used in this study. This potentially indicates
a direct relationship between BBB leakage and microglial activation that drives the
inflammatory cascade forward. The hypothetical models suggested by the Tresco,
Bellamkonda, and Capadona groups explain the mutual influence of pro-inflammatory
cytokines secreted by activated microglia permeabilizing BBB and pro-inflammatory
cytokines secreted by infiltrated myeloid cells stimulating microglia [58,101,133,142].
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Fig. 5.6. Correlation coefficients of the reactivity of immunolabels
along the distance from the implant. Values shown above bars are
mean. Error bars are standard error mean. (N=16)
Neurons are intoxicated by both of these activities but are not actively involved in
driving the cascade, potentially explaining why NeuN-1 is only loosely correlated.
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5.6 Conclusion
We have evaluated the FBR of implanted microelectrodes with regard to coat-
ing scheme (PEG-coat vs. no-coat) and animal strain (CX3CR1-GFP vs. WT) at
four weeks. Although we observed less adherent-microglia on the PEG-coated de-
vices, statistical analyses suggested that dip coating with PEG does not result in a
significant decrease or increase in the FBR. Likewise, the use of a transgenic CX3CR1-
GFP mouse model did not induce any significant difference in FBR compared to the
WT mice. These results indicate that PEG-coating and the CX3CR1-GFP mouse
model do not confound neural implant studies that use such materials for varying
purposes. This study validates that 1) PEG-coating is a suitable insertion carrier or
aid that can be used in applications such as insertion of flexible neural probes, and
2) CX3CR1-GFP is a suitable model that can be used for immunohistochemistry or
in vivo imaging for studying the neuro-inflammatory cascade to implanted devices.
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6. SUMMARY
The work in this thesis interrogates several electrode design factors by examining
histological and electrophysiological hallmarks. The work presented in Chapter 3
demonstrates that, although substrate form factor dictates the overall FBR, putting
sites on the edge can leverage relatively non-severe region. The work presented in
Chapter 4 shows that flexible substrates do reduce the FBR but the benefit from
flexibility does not increase proportionally with increasing flexibility and reaches a
beneficial limit. The work presented in Chapter 5 shows that dip-coating with PEG,
which is employed in many flexible electrode studies including Chapter 4, does not
significantly alter the FBR and thus does not confound the histological analysis.
These findings can make a seminal contribution toward identifying the factors per-
taining to an ideal intracortical implant. They raise additional design factor consid-
erations. For example, as a bulky shank look to deteriorate the FBR, replacing the
whole shank with a rigid dissolvable agent can be a viable option to minimize the
tissue response. Findings also enrich scientific inquiry. For example, what might be
the mechanism for the flexibility threshold hypothesis? How does mechanotransduc-
tion come into play in this scenario? By observing the increase in insertion profile
from the thick PEG-coating not exacerbating the chronic FBR, is the FBR truly in-
fluenced by the chain reaction initiated from the insertion injury? Or does PEG have
curative effect on the damaged cortical tissues? Answering these will likely raise more
questions, but iterating this positive loop will advance the field of neural implants.
Biological response to neural implants is currently the major limiting factor for the
functional longevity. With the presented findings, there is still a long way ahead to
overcome the posed limitations. Very often the findings from the PNS does not pertain
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to the CNS and vice versa due to the inherent difference in cellular compositions.
Even within the CNS we have seen that a small modification to the design (e.g.,
site placement) can significantly alter the outcome. Therefore, hasty conclusions are
discouraged. A careful step-by-step approach to identify the key features will be the
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